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1 INTRODUCTION 
 
A successful drug discovery and development process includes selecting the right 
disease target, identifying the compound, and executing a functional development 
process. Absorption, distribution, metabolism, excretion and toxicity (ADME/tox) 
screening is a major part of the early drug discovery process, where the most suitable 
drug candidates for the clinic are selected. Drug permeability plays a critical role e.g. in 
oral absorption, blood-brain barrier permeation, cell-membrane penetration for the 
intracellular targets and skin absorption of transdermal products. Therefore, 
permeability has a significant influence on drug absorption and disposition, metabolism 
and transporter effects, and pharmacokinetics-pharmacodynamics relationships. The 
permeability is also, along with solubility, the key determinant for the 
Biopharmaceutical Classification System (BCS) (Amidon et al. 1995).  
 
For orally administered drugs, one of the prerequisites for successful therapy is 
sufficient intestinal absorption. If the drug candidate has a proven pharmacological 
effect, but it is absorbed very poorly from the gastrointestinal track, its oral 
administration is not possible. Therefore, the absorption potential of molecules is 
studied in the early stage of the drug development process. The prediction is not easy 
because in vivo absorption from the intestine is affected by a great number of factors 
e.g. the solubility and permeability of a drug, membrane transporters, the integrity of the 
gastrointestinal tract, presystemic drug metabolism, physiological status and 
formulation. Various permeability assays have been developed and applied in the drug 
discovery and development process to predict intestinal absorption, including in silico, 
in vitro, in situ, and in vivo approaches. However, traditional in vitro cell assays are 
often static, time-consuming and laborious. This is particular true for those assays 
requiring further analytical procedures where the final detection is based on UV 
spectroscopy, mass spectrometry, or radiometry of labeled compounds. Furthermore, in 
situ and in vivo animal experiments are ethically questionable.  
 
Surface plasmon resonance (SPR) is a label-free optical detection instrument which 
allows real-time monitoring without labeling of the analyte (Kooyman 2008). Usually, 
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in a traditional SPR application, one of the interacting biomolecules is immobilized on 
the surface of the gold sensor chip and the analyte is injected onto the chip to detect the 
interaction between them. This technique has often been used for the analyses of 
interactions between the analyte and various kinds of biomolecules such as peptides, 
proteins, nucleic acids, and polysaccharides (Rich and Myszka. 2010; De Crescenzo et 
al. 2008). SPR has found applications at many stages of the drug discovery process, 
particularly in ligand discovery and lead optimization (Cooper 2002). It has been used 
to directly monitor the binding of low molecular weight compounds to immobilized 
drug targets in order to determine affinity constants and reaction kinetics. Additionally, 
SPR has been applied in ADME assays to predict absorption by studying the binding of 
small molecules to liposome surfaces immobilized on the sensor chip surface (Danelian 
et al. 2000; Cimitan et al. 2005; Frostell-Karlsson et al. 2005). A new emerging 
application for SPR is the analysis of cellular processes at the whole-cell level where 
cells are immobilized directly on the sensing surface and stimulated with test 
compounds (Robelek and Wegener 2010; Chabot et al. 2009; Fujimura et al. 2008).  
 
The literature part of this work focuses on the permeability of drug molecules and 
reviews the experimental and computational methods that are widely applied to predict 
the permeability of drugs across the intestinal membrane. The current biosensor and 
whole-cell applications of the SPR technique are also reviewed in order to clarify the 
potential of using the SPR technique to study drug-cell interactions, drug absorption 
routes and cell uptake mechanisms. The experimental part of this work evaluates the 
suitability of SPR for small molecular drug-cell interactions studies with ARPE-19 and 
MDCKII cell lines. 
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2 DRUG PERMEABILITY ACROSS INTESTIAL EPITHELIUM 
 
The oral drug delivery is the most preferred route of drug administration. The oral route 
is preferred because of its convenience, low costs, and high patient compliance 
compared to other routes. For orally administrated drugs, the amount of drug reaching 
the blood circulation depends e.g. on the permeability and solubility of a drug, the 
gastrointestinal pH, gastric emptying, gastrointestinal transit, the presystemic 
elimination, and the formulation (Barthe et al. 1999). Transport of drug substances 
across the intestinal membrane is a complex and dynamic process and it may include 
the passage of compounds across various pathways at the same time. Passive transport 
takes place through the cell membrane of enterocytes (transcellular) or via the tight 
junctions between the enterocytes (paracellular). Various influx and efflux transporters 
can also be functional during absorption. This chapter focuses on the permeability of the 
drugs across the intestinal membrane. 
 
2.1 Intestinal membrane 
  
Approximately 90% of all absorption in the gastrointestinal track occurs in the small 
intestinal region (Balimane and Chong 2005). The anatomy and physiology of the 
intestinal membrane have a major impact on the absorption process. The physiological 
role of the small intestine is the selective absorption of nutrients and to serve as a barrier 
to digestive enzymes and ingested foreign substances. The length of the human small 
intestine is approximately 2-6 m. It is divided into duodenum, jejunum and ileum which 
comprise 5%, 50%, and 45% of the length. There is microvillus on the surface of the 
intestine, which greatly increases the surface area available for absorption. The 
intestinal membrane consists of enterocytes, goblet cells that secrete mucin, endocrine 
cells, paneth cells, M cells, tuft, and cup cells. The absorption occurs mostly across 
enterocytes. The enterocytes are polarized cells which are separated by tight junctions.  
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2.2 Passive diffusion 
 
The cellular membrane is a lipid bilayer composed of various amphiphilic 
phospholipids, cholesterol and proteins (Sugano et al. 2010). It forms a thin, 
(approximately 5 nm) hydrophobic barrier which separates the cell interior from the 
extracellular aqueous environment. Passive diffusion is a concentration gradient-driven 
mass transport of compound across the cell membrane which is not consuming energy 
(ATP). Passive diffusion follows Fick’s law, whereby the absorption rate is proportional 
to the drug concentration and the surface area. Passive diffusion can be divided into 
transcellular or paracellular processes, as shown in Figure 1. Transcellular diffusion 
through a membrane occurs across the lipid bilayer of enterocytes. The center of the 
lipid bilayer is highly hydrophobic; therefore a compound diffuses across lipid bilayer 
mainly as an uncharged molecule. Transcellular transport generally depends on the 
uncharged fraction of the compound defined by the pKa of the molecule and the 
physicochemical properties of the molecule, such as lipophilicity (log P/log D), polar 
surface area, hydrogen bond number and molecular size.  
 
Passive paracellular diffusion in the intestine occurs via the tight junctions between the 
cells (Figure 1). The molecules with molecular weight approximately <200 g/mol may 
use this transport route (Fagerholm et al. 1999). For larger molecules, it is considered as 
a minor transport route because of the limited intercellular space. The available surface 
area for paracellular intestinal absorption has been estimated to be approximately as low 
as 0.01% of the total surface area of the small intestine (Madara and Pappenheimer 
1987). However, paracellular transport may be an important absorption mechanism for 
hydrophilic drugs that have poor membrane permeability and that are not transported 
via intestinal uptake carriers. 
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Figure 1. Transport mechanisms through the intestinal membrane (Sugano et al. 2010). 
 
 
2.3 Carrier-mediated transport 
 
Carrier-mediated transport of drugs occurs through specific cells that express the 
transporter and the binding is stereospesific, and often enantioselective (Sugano et al. 
2010). When the transport process directly or indirectly consumes energy (ATP), the 
transport process is active and does not require any concentration gradient of the 
compound. Carrier-mediated transport occurs via transporters, which can transport 
drugs into (influx) a cell or out of a cell (efflux). In the case of primary active transport, 
transporters require binding and the hydrolysis of ATP to operate. While in the case of 
secondary active transport, transporters are driven by ion gradients created by ATP-
dependent primary transporters, such as Na+/K+-ATPase. However, carrier-mediated 
transport can also occur passively and is then driven by the concentration of the 
substrate (facilitated transport). The carrier-mediated transport is saturable. The 
saturation occurs when the total number of molecules exceeds the number of carrier 
protein binding sites available for transport.   
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There are more than 400 membrane transporters in humans (Giacomini et al. 2010). 
Two major superfamilies are the ATP-binding cassette (ABC) and the solute carrier 
(SLC) families. The clinically significant uptake and efflux transporters of the drugs in 
the intestinal membrane are shown in Figure 2. If the drug is a substrate of a transporter, 
it is translocated across a membrane by the transporter. An inhibitor of a drug 
transporter can decrease the influx and/or efflux of the drug competitively or non-
competitively, whereas an inductor of a drug transporter can increase the transport. The 
carrier-mediated transport via uptake transporters is a crucial absorption mechanism for 
some drugs, but it can also cause clinically significant interactions between drugs. 
 
 
Figure 2. Most important transporters in the intestinal epithelia. There are several 
uptake receptors in the apical membrane of the enterocyte including transporters of the 
organic anion transporting polypeptide (OATP) family, peptide transporter 1 (PEPT1), 
ileal apical sodium/bile acid co-transporter (ASBT) and monocarboxylic acid 
transporter 1 (MCT1). The efflux transporters include multidrug resistance protein 2 
(MRP2), breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp). The 
basolateral membrane contains organic cation transporter 1 (OCT1), heteromeric 
organic solute transporter (OST!-OST") and MRP3 (Edited from Giacomini et al. 
2010).  
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2.4 Endocytosis 
 
Endocytosis is an uptake mechanism for the uptake of macromolecules, which is 
consuming energy (Conner and Schmid 2003). In endocytosis, macromolecules are 
transported into the cell in membrane-bound vesicles derived from the cell membrane. 
Endocytosis may occur via phagocytosis or pinocytosis, but phagocytosis is typically 
restricted to specialized cells, including macrophages, monocytes and neutrophils. 
However, pinocytosis occurs in all cells by multiple mechanisms: macropinocytosis, 
clathrin-mediated endocytosis, caveolae-mediated endocytosis, and clathrin- and 
caveolae-independent endocytosis. Nanoparticles and large peptides may be absorbed 
by the intestinal epithelium via endocytosis (Anderson et al. 2001; Gao et al. 2011). 
Therefore, nanoparticle mediated drug delivery systems may be effective for enhancing 
the intestinal absorption of the drugs that have a low oral bioavailability. 
 
 
3 METHODS TO PREDICT INTESTINAL PERMEABILITY OF DRUGS 
 
Several permeability assays have been developed and applied in the drug discovery and 
development process to predict intestinal absorption, including in silico, in vitro, in situ, 
and in vivo approaches. This chapter reviews relatively rapid in vitro and in silico 
methods that are used in the early drug discovery process for the prediction of intestinal 
permeability of lead compounds in humans. 
 
3.1 In vitro methods 
 
3.1.1 Artificial membrane models 
 
In 1998, Kansy et al. introduced the parallel artificial membrane permeability assay 
(PAMPA) to predict transcellular absorption of drugs in the intestine. PAMPA is based 
on a 96-well microtiter plate technology, where the plate is covered with a microtiter 
filter plate in a sandwich construction. Each composite well is divided into a donor and 
an acceptor chamber, which are separated by a hydrophobic permeability filter. The 
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lipid membrane is formed on the filter and the flux factors between a donor and an 
acceptor compartments are measured. The membrane is completely artificial without 
any paracellular pathway and active transporters. Therefore, only the human absorption 
of transcellularly transported compounds can be predicted reliably.  
 
During the past decade, several enhanced variants of PAMPA have been developed by 
different researchers, including differences in membrane composition, solution 
composition, and hydrodynamics. First Kansy and co-workers used (1998) a lipid 
barrier formed by a mixture of egg-lecithin and n-dodecane. Later the composition of 
the lipid membrane has been varied e.g. to dioleoyl phosphatidylcholine in dodecane, 
and n-hexadecane alone to develop even faster, simpler and a more robust method to 
predict passive, transcellular permeability (Avdeef et al. 2001; Wohnsland and Faller 
2001). Avdeef et al. (2004) introduced a modification of PAMPA where stirring of the 
donor compartment was used. The stirring decreased permeation time of lipophilic 
drugs significantly and allowed faster analyses. The double-sink PAMPA method was 
also introduced by Avdeef at al. (2005) to stimulate the transit. In this method, the 
donor compartment consisted of pH gradient “sink” for acids and lipophilic gradient 
“sink” for bases in acceptor compartment and also an individual-well magnetic stirring 
mechanism.  
 
PAMPA is a simple and fast physicochemical method in order to predict passive 
transcellular permeability of compounds (Kansy et al. 1998; Avdeef et al. 2007). The 
advantage of this method is a higher throughput and relatively lower cost compared to 
cell-based permeability assays. Due to the ability of screening thousands of compounds 
a day, PAMPA is a useful tool in the early phase of drug discovery to screen the 
libraries in order to predict passive oral absorption. Moreover, PAMPA can provide 
information on the lipophilicity, the ionization state, and the solubility of a compound. 
As in cellular models, a significant unstirred water layer may exist within the PAMPA 
model. Without stirring, the thickness of the unstirred water layer has been estimated to 
vary from approximately 2000 to 4000 µm, but a value as low as 300 µm have been 
shown when plates were lightly shaken (Wohnsland and Faller 2001; Avdeef et al. 
2004). The thickness is thought to be <100 µm in vivo (Levitt et al. 1990). Thick 
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unstirred water layer can represent the rate-limiting step for determining permeation for 
poorly soluble lipophilic drugs, thus complicating the predictability of in vivo 
permeability. 
 
3.1.2 Cell culture monolayers 
 
In vitro experiments using cultured cell monolayers are one of the most often applied 
methods in order to estimate the intestinal absorption of drug candidates in the 
preclinical phase. The cells are grown on semi-permeable filters to form monolayers, 
which morphologically resemble the intestinal epithelium (Irvine et al. 1999). The 
monolayers are grown on filter supports and the passage of a drug from the apical to the 
basolateral compartment and the basolateral to the apical is measured. Unlike lipid-
based artificial membrane models, cell culture-based models have structural and 
biological properties characteristic of differentiated intestinal epithelia. Because cells 
express various drug transporters and metabolic enzymes, the models have the 
capability to study permeability properties other than just passive transcellular diffusion 
(Seithel et al 2006). However, there are also a number of disadvantages in the models. 
Several factors can induce the assay variability such as culture time, seeding density, 
passage number, and culture conditions, and those can affect cellular properties (Volpe 
2008). In addition, the extensive culture times before assays makes the cell-based 
permeability studies laborious with high costs.  
 
Human colon carcinoma (Caco-2) cell monolayer model is widely used as a tool for 
evaluating human intestinal permeability (Press and Di Grandi 2008). Caco-2 cells 
differentiate spontaneously structurally and functionally into a cell monolayer with 
polarization that has functions similar to intestinal enterocytes (Hidalgo et al. 1989). 
Furthermore, they express similar drug transporters as the human small intestine, but the 
expression of the most well-known drug transporters is lower in Caco-2 cells than in 
human enterocytes (Seithel et al. 2006). A qualitative relationship between in vitro 
Caco-2 cellular transport and in vivo drug permeability has been established by several 
researchers (Lennernäs et al. 1996; Irvine et al. 1999; Skolnik et al. 2010). In 1996, 
Lennernäs et al. observed that drugs with rapid and complete passive transcellular 
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transport had comparable permeability between Caco-2 cells and in vivo human 
jejunum. However, the uptake was observed to be lower in Caco-2 cells, when the 
tested compounds were using the paracellular pathway or carrier-mediated uptake 
transport. Thus, the Caco-2 assay has been shown to be more predictive of human 
absorption for certain classes of drugs than others because of differences in the 
paracellular radius and transporter expression. The disadvantage the performance of the 
absorption studies with this cell line is also a relatively low high-throughput capability 
due to the 3-weeks culture period resulting in high costs. Therefore, a 96-well Caco-2 
assay has been developed in order to achieve higher throughput permeability assessment 
with cells (Skolnik et al. 2010; Mariano et al. 2005). It should be noted that the results 
from Caco-2 cell permeability assays can exhibit significant inter-laboratory variability, 
because of differences in cell source, passage number and culture conditions (Hayeshi et 
al. 2008). Even small differences in the culture conditions may have a significant impact 
on transporter expression in Caco-2 cells.  
 
The Madin-Darby canine kidney (MDCK) epithelial cell line has been used in 
permeability assays because of its faster maturation time in culture compared to Caco-2 
cells (Irvine at al. 1999). MDCK cells form a columnar epithelium and tight junctions 
when cultured on semi-permeable membranes. Although the cell line is derived from 
the renal epithelia of a canine, it has been reposrted that permeability results from 
MDCK cells are similar to permeability results from Caco-2 cells for passively 
absorbed drugs. In addition, MDCK cells have a relatively low expression of drug 
transporters making it suitable for the prediction of passive absorption (Braun et al. 
2000). However, for better prediction for permeability MDCKII-LE (low efflux) cell 
line has been developed having fivefold lower canine P-glycoprotein protein level than 
MDCKII-WT (Di et al. 2011). This cell line may provide benefits over MDCKII-WT 
with less background transporter signals and less probability of interference from canine 
P-glycoprotein. 
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3.1.3 Surface plasmon resonance technique 
 
The SPR technique has already been used in the pioneering studies of drug interactions 
with lipid membranes resembling the intestinal membrane for predicting intestinal 
permeability (Danelian et al. 2000; Cimitan et al. 2005; Frostell-Karlsson et al. 2005). 
Liposomes are captured on a sensor chip to create a lipid barrier representative of an 
intestinal epithelial cell. The stagnant aqueous layer next to the lipid surface mimics the 
unstirred water layer of the intestinal mucosa. Then the interactions between drugs and 
immobilized liposomes are monitored by SPR without the need for intrinsic or extrinsic 
labeling agents. The interaction is measured in real-time and not only binding level but 
also interaction kinetics are monitored directly. 
 
Danelian et al. (2000) applied SPR in order to study the interactions between 27 
compounds and liposomes immobilized on the sensor chip. The results from SPR 
measurements were compared to reliable estimates for the drug fraction absorbed from 
the intestine (Fa) in human. The results revealed that the SPR technique can be used to 
predict Fa in humans for drugs using the transcellular absorption route. Later in 2005, 
the interactions between 78 drug compounds and immobilized liposomes were studied 
(Frostell-Karlsson et al. 2005). Based on these results, it was possible to divide the 
compounds into groups of high, medium, or low level of absorption. Moreover, SPR has 
been successfully applied to predict the interaction between drugs and the intestinal 
surface using a sensor chip on which brush border membrane vesicles from a rat were 
immobilized (Kim et al. 2004; Kim et al. 2005). The results of these studies 
demonstrated that immobilized brush border membrane surfaces on the sensor chip 
closely mimic the surface of the small intestine in human. Kim et al. (2004) found that 
the method provided important information that predicts Fa in humans for transcellularly 
absorbed drugs. 
 
It has been suggested that the SPR based assay could be used prior to other more 
complex screens to eliminate compounds that are likely to show low absorption in vivo 
(Frostell-Karlsson et al. 2005; Kim et al. 2004). The SPR based assay predicts only 
passive absorption, because active transport routes and enzymes are not expressed. 
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Certainly, the influence of active transporters needs to be measured with specific 
transporter assays. However, the SPR based assay could also be beneficial to use along 
with other in vitro data to predict whether the rate-determining step in the absorption of 
a compound will be due to transporter affinity as opposed to membrane affinity. In 
addition, the interaction between a drug and liposome can be investigated under a wide 
range of conditions that mimic various in vivo membrane environments e.g. under 
different hydrodynamic flow conditions, which directly reflects the unstirred water layer 
thickness (Baird et al. 2002). 
 
3.2 In silico methods 
 
Numerous computational structure-based models to predict passive intestinal absorption 
have been published (Hou et al. 2006). The attempt is to establish a relationship 
between different molecular properties and the absorption in humans. The most widely 
used computational approach to the coarse estimation of passive intestinal absorption is 
“rule of 5” proposed by Lipinski and coworkers in 1997 from the analysis of 2245 drugs 
from the World Drug Index. It presents that poor absorption is more probable for 
compounds with molecular weight > 500 Da, calculated LogP >5, a number of 
hydrogen donors >5 and number of hydrogen bond acceptors >10. The rule can only be 
used to rapidly distinguish between well-absorbed molecules and poorly-absorbed 
molecules, and therefore it has been necessary to develop prediction models for specific 
absorption properties. 
 
Most computational prediction methods applied in the estimation of drug absorption are 
using data modeling (Hou et al. 2006). Data modeling can be applied with great 
efficiency to a large number of compounds, but it requires a significant quantity of high 
quality data to deduce a relationship between the structures and the modeled property. 
Therefore, the reliability and applicability of a computational model is highly dependent 
on the quality of the dataset used during model development. Typically, models applied 
to predict intestinal absorption, are quantitative structure-property relationship (QSPR) 
models which are based on appropriate descriptors. QSPR modeling is developed from 
simple multiple linear regression to modern multivariate analysis techniques or 
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machine-leaning methods. Many import physicochemical descriptors are introduced 
into the prediction of drug absorption, such as polar surface area, lipophilicity 
parameters (logP, LogD), molecular weight, and the number of hydrogen bond 
acceptors and donors. However, it is not possible to determinate drug absorption by 
single defined descriptor, but rather by the combination of different physicochemical 
descriptors. 
 
Several QSAR approaches have been proposed to predict human intestinal absorption 
and Caco-2 cell permeability (Gozalbes et al. 2011; Suenderhauf et al. 2011; Wessel et 
al. 1998). Linnankoski et al. (2008) demonstrated that computationally derived 
mathematical models can predict with a reasonable accuracy human passive absorption, 
when models were compared to cell lines, artificial membrane models, and in vivo rat 
experiments. The results showed that three of seven models were found to be 
significantly more reliable in predicting human passive intestinal absorption than the 
artificial membrane models. Two of the models were found to be as reliable as the 
Caco-2 and 2/4/A1 cell lines. Moreover, one of the computational models even 
predicted the absorption of drugs nearly as well as absorption studies on rats. Therefore, 
the simple computational models with high throughput are particularly useful tools in 
the early screening of drug candidates to predict intestinal passive absorption. 
 
 
4 SURFACE PLASMON RESONANCE SPECTROSCOPY 
 
SPR-based biosensing is one of the most advanced label-free, real-time detection 
technique. The first application of SPR for gas detection and biosensing was 
demonstrated in 1983 by Liedberg and coworkers. Today, SPR is employed in 
important applications in food safety, biology, medical diagnostics, and drug discovery 
(Copeer 2002; Homola 2008). This chapter focuses on the principle of the SPR method 
and cell-based SPR applications that have been applied so far. 
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4.1 Principle of surface plasmon resonance biosensing 
 
SPR spectroscopy is an optical method, which measures the change in the refractive 
index on a surface of metal (Kooyman 2008). The detection principle relies on an 
electron charge density wave phenomenon that occurs on the surface of a metallic film 
when light is reflected at the film under particular conditions. The first demonstration of 
optical excitation was made by Otto, Kretschmann and Raether (Kretschmann and 
Raether 1968; Otto 1968). A typical experimental set-up of the SPR measurement using 
the so called Kretschmann configuration is shown in Figure 3.   
 
 
Figure 3. The principle of SPR detection using the conventional Kretschmann optical 
configuration. SPR detects changes in the refractive index in the immediate vicinity of 
the sensor surface. It appears as a sharp dip in the reflected light from the surface at an 
angle that is dependent on the mass of molecules on the surface (left bottom image). 
The SPR angle shifts when molecules bind to the surface and mass on the surface is 
changed. The change is monitored by plotting the resonance angle signal versus time in 
a so called sensorgram (right bottom image) (Cooper 2002).  
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The evanescent wave is essential in the concept of SPR sensing (Kooyman 2008). The 
refraction of the evanescent wave at the interface between two media with refractive 
indexes n1 and n2 follows Snell’s law (equation 1). The equation reveals the direction of 
light after refraction. 
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When p-polarized light is directed at an interface between a metal and a dielectric 
material, Fresnel’s equations reveal how much of the light is refracted and how much is 
reflected (Kooyman 2008). The complex reflection coefficient rp for p-polarized 
incident light electric field in the interface between two media is defined by the Fresnel 
equation: 
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where Ei and Er are the incident and reflected electric fields, respectively, and the angle 
! is the incident angle and " the angle of refraction. Surface plasmons are charge-
density oscillations occurring at the interface between a metal and a dielectric. The 
wave vector of the surface plasmon wave (Ksp) is defiened by equation 3:   
 
! 
Ksp =
"
c
#M nD
#M + nD
 ,  (3) 
! 
where ! is the angular frequency, c the speed of the light, #M the metal permittivity and 
nD the dielectric refractive index. A coupling method between the prism or grating, and 
the metal surface is required for surface plasmon resonance to occur (Figure 3). The 
coupling matches the wavevectors of the incident light and the surface plasmons 
enabling the electromagnetic field component of the p-polarized light to penetrate to the 
metal layer and transferring energy to the free electrons on the metal surface. This 
energy transfer produces surface plasmons at the metal-dielectric interface. As a result 
of the energy transfer, the coupling appears as a sharp dip in the measured reflectance as 
a function of a specific angle of incidence which is illustrated in Figure 3 (left bottom 
image). The reflection at the metal-dielectric interface generates an evanescent field in 
both the metal and the dielectric media propagating approximately 300 nm into the 
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dielectric media. When the prism refractive index and the laser wavelength are kept 
constant, the conditions for maximum coupling will change with a modification of the 
medium refractive index, which is caused for example by the adsorption and desorption 
of molecules on the surface. As a summary, when a molecule absorbs or binds to the 
gold surface, the local refractive index change leads to a change in the SPR signal. The 
size of the change in SPR signal is directly proportional to the mass immobilized onto 
the surface. The SPR signal measured usually is the SPR peak minimum position (angle 
or wavelength) or the intensity change at a fixed angle near the minimum of the SPR 
peak depending on the SPR instrument used. 
 
4.2 Surface plasmon resonance instrumentation 
 
SPR instruments contain at least three integrated components: SPR instrumental optics, 
a liquid handling system and a sensor chip (Schasfoort and McWhirter 2008). The 
properties of the gold sensor chip have a vital influence on the quality of the 
measurements. The gold sensor chip is a physical barrier between the dry optical unit 
and the wet flow channel. Instruments differ in performance based on differences in 
optical systems and a degree of development and automation. The optical systems with 
prism, gratings and optical waveguides are applied to excite surface plasmons. In prism 
configuration, also called the Kretschmann configuration, a prism couples p-polarized 
light in to the gold film and reflects the light on a light intensity detecting device using a 
photodiode or a camera. The Kretschmann configuration can be further divided into fan-
shaped beam, fixed angle and angle scanning SPR instruments. In a grating coupler, 
light is reflected at the lower refractive index substrate, whereas some instruments have 
optical waveguide couplers where the shift of SPR wavelength is followed. All 
configurations are measuring the change of refractive index directly, in real-time and 
without any labels. 
 
Three major liquid handling systems are the flow channels, the cuvette and the 
microfluidic chip (Schasfoort and McWhirter 2008). Peristaltic or syringe pumps are 
used to pump the liquid onto the sensor surface, whereas the samples are transported by 
syringes or peristaltic pumps with or without pneumatic valves and sample loops. Some 
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instruments have an automatic injection system and some are applied manually. The 
flow channels are formed when microfluidic channels are pressed against the sensor 
chip. The planar flow channels are mostly employed in SPR instruments and confined 
wall-jet flow channels and hydrodynamic flow channels are less common. A planar 
flow channel is comprised of a single broad channel with an inlet and outlet, from 
which liquid flows and interacts with the sensor surface. The cuvette liquid handling 
system is formed by an open container which is manually or automatically filled with 
liquid. The cuvette is placed on the sensor surface and reactions occur at the bottom of 
the cuvette. The cuvette requires a mixing system in order to gain more reliable 
sensorgrams. The disadvantage of the cuvette system is its open architecture which 
allows the evaporation of the sample solution.  
 
4.3 Biochemical-based assays 
 
4.3.1 Functionalization of the sensor surface 
 
Usually, a sensor chip is functionalized for SPR measurements by attaching one of the 
interacting molecules, biorecognition element or target molecule, onto the surface of the 
sensor surface (Homola et al. 2008). Which of the molecules is immobilized depends on 
the used sensing scheme. In direct, sandwich, and competitive assay, the biorecognition 
element is immobilized, but in the inhibition assay the immobilized molecule is the 
target molecule or its derivate. The detection formats are reviewed in detail in the next 
section (4.3.2). The choice between biorecogition element and an immobilization 
method is critical because it is affecting the performance of the assay such as sensitivity, 
specificity, and the limit of detection.  
 
The interacting molecules can be immobilized either on a surface of the sensor chip or 
in a three-dimensional matrix. The main approaches for immobilizing of molecules to 
the sensor surface are based on physical, covalent or bioaffinity immobilization 
(Koubova et al. 2001; Busse et al. 2002; Lee et al. 2005).!The covalent immobilization 
strategies include chemical reactions such as amine, aldehyde or thiol coupling (Löfås et 
al. 1995). Self-assembled monolayers (SAMs) of alkanethiols or disulfides have been 
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widely used for a covalent immobilization of biomolecules (Lahiri et al. 1999; Lee et al. 
2005). SAMs of oligo(ethylene glycol)-tethered molecules are used to reduce a non-
spesific binding of molecules on the sensing surface (Zareie et al. 2008). Also 
polymeric layers such as carboxylated dextran can be used for covalent binding (Löfås 
et al. 1995). It has been shown that there is no difference in binding kinetics between 
SAMs and a dextran hydrogel (Lahiri et al. 1999). Another approach for the 
immobilizing the biorecogition element is based on biochemical affinity reactions using 
the biotin/streptavidin system (Busse et al. 2002). In this method, the protein 
streptavidin is immobilized on the gold surface providing binding sites for a subsequent 
attachment of biotin-conjugated protein. Clearly, the selection of the functionalization 
strategy is mainly application driven. 
 
4.3.2 The detection formats 
 
Biochemical assays performed with SPR can be divided into four different sensing 
schemes that are typically applied. Those are direct assays, sandwich assays, 
competitive assays, and inhibition assays (Figure 4). With a direct binding assay format 
the interaction between a receptor and an analyte is investigated (Homola et al. 2002). 
In a direct assay a receptor of a medium- and large-molecular weight molecule is 
chemically bonded to the gold surface of the SPR sensor chip (Figure 4A). 
Macromolecules bind to the immobilized receptors which produces a local increase in 
the refractive index. This increase in the refractive index is measured and can be 
correlated to the amount of captured analyte. However, the direct assay is only useful 
for the detection of large molecules because small molecules have often a too low mass 
to produce a measurable change in the refractive index. Homola and coworkers (2002) 
used a direct assay in SPR measurements for detection of staphylococcal enterotoxin B 
in milk, and the SPR was shown to be capable of directly detecting concentrations of 
staphylococcal enterotoxin B in a buffer as low as 5 ng/ml. 
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Figure 4. Main sensing schemas used in SPR bioassays: (A) direct assay, (B) sandwich 
assay, (C) competitive assay, and (D) inhibition assay (Edited from Homola 2008). 
 
 
A sandwich assay consists of two steps (Figure 4B) (Homola et al. 2002). First the 
antibody is immobilized onto the sensor chip following the binging of the analyte. In the 
second step, a secondary antibody is injected over the sensing surface in order to bind to 
the earlier captured analyte. This format is used to enhance sensitivity and specificity. In 
addition to the direct assay, the sandwich assay was also used in Homola’s et al. study 
to amplify a sensor response and verify the binding of the analyte. The detection limit of 
0,5 ng/ml of staphylococcal enterotoxin B both in milk and buffer was achieved. The 
detection limit was 10-fold lower than in the direct detection assay. Yao and coworkers 
(2006) used the sandwich assay in order to analyze oligonucleotide and polynucleotide 
samples with low concentrations by utilizing gold nanoparticles to enhance the SPR 
signal. For the analysis of a 39-mer target DNA, the detection limit was in the 
femtomolar range and the amount of sample needed per analysis was only 15 µl. 
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The competitive assay is based on two samples (Figure 4C) (Shimomura et al. 2001). In 
one sample the small analyte is free and in another it is conjugated to a larger protein. 
Both samples are competing for the same recognition molecules immobilized on the 
SPR sensor surface. In this method, the decrease in the signal is proportional to the 
amount of target sample. The concentration of the conjugated sample is known while 
the concentration of the free sample is unknown. Shimomura and his research group 
developed a rapid method in order to quantify endocrine disrupting chemicals, 2,3,7,8-
TCDD, polychlorinated biphenylx, and atrazine, from the buffer using a competitive 
assay. The competitive method was performed because low-molecular-weight analytes 
did not give any SPR signal in a direct assay, thus binding to the antibody was not 
observed. However, the detection limit of all test compounds was between 0,1-5 ng/ml 
using the competitive method. 
 
In the inhibition assay, an analyte or its analogue is immobilized on the sensor surface 
(Figure 4D) (Fitzpatrick and O’Kennedy 2004). A fixed concentration of an antibody 
with affinity to an analyte is mixed with a sample containing an unknown concentration 
of the analyte and then, the mixture is injected to the sensing surface. The binding of the 
unreacted antibodies is measured as they bind to the analyte molecules immobilized on 
the sensor surface and therefore the sensor response is inversely proportional to the 
concentration of the free analyte in the solution. Fitzpatrick and O’Kennedy (2004) used 
the inhibition assay in order to detect physiologically active a nonprotein-bound fraction 
of warfarin in plasma ultrafiltrate. The assay precision range was approximately 4-250 
ng/ml, which is within the clinical range. 
 
4.4 Cell-based assays 
 
A new emerging application for SPR is the analysis of cellular processes at the whole-
cell level (Hide et al. 2002). The SPR technique provides a non-invasive method in 
order to investigate cellular responses in living cells in real-time. In 2002, Hide et al. 
suggested that SPR might have the capacity to detect a variety of cellular responses. 
Since then, several applications have been introduced where SPR have been used to 
examine a diverse array of cellular processes with various types of cells (Fujimura et al. 
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2008; Chabot et al. 2009; Chen et al. 2010). In those applications, the cells were 
cultured directly on the gold sensor chip followed by the stimulation with an external 
agent and cell responses were analyzed by using reflectance or angular change 
information. The real-time monitoring of cellular activation is possible by SPR because 
the stimulation often induces morphological changes, such as a cell contraction and 
spreading. These changes should affect the basal portion of the cell, which lies within 
the evanescent field of the surface plasmon (Figure 5). The evanescent field on the 
surface is approximately 300 nm, while the thickness of a cell is several µm:s, meaning 
that only the bottom portion of cells can be sensed by SPR. The other approach 
introduced is the application where an analyte is immobilized on the gold sensor chip 
while suspension of intact cells is introduced on the surface (Mizuguchi 2012). This 
approach can only be applied to detect specific ligand-receptor interactions. This section 
reviews the cell-based SPR studies where cells are immobilized directly on the gold 
sensor chip. 
 
 
Figure 5. Schematic diagram of SPR sensor immobilized with cells with a Kretschmann 
configuration (Edited from Robelek and Wegener 2010). 
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4.4.1 Intracellular reactions induced by stimulation with external agent 
 
In 2002, Hide at al. first introduced that SPR can be applied to the analysis of 
interactions between living cells and molecules reactive to the cells, using mast cells 
and mast-cell reactive antigens. The IgE-sensitized mast cells were immobilized on the 
gold sensor chip and stimulated by an antigen. The exposure of the antigen to the 
immobilized cells induced a robust and long-lasting increase of the SPR angle in a dose 
dependent manner. The maximal increase in the SPR angle induced by the antigen was 
approximately 1000 times higher than the theoretically expected increase for the simple 
binding of the antigen to the receptor. These results suggest that SPR can detect 
intracellular signaling, and not just simple binding kinetics between the receptor on the 
cell surface and their ligands. Tanaka et al. (2008) studied in detail the molecular events 
that are responsible for a major change in the SPR angle, when RBL-2H3 mast cells 
were stimulated with the antigen, by using the genetic manipulation of intracellular 
signaling molecules. The SPR analysis was done by immobilizing the cells 
overexpressing and/or having a defect in the intracellular signaling molecules on the 
gold sensor chip followed by the simulation with the antigen. The results indicated that 
the antigen-induced increase of the SPR angle in RBL-2H3 cells is greatly dependent on 
the activation of spleen tyrosine kinase, a linker for activation of T cells, Grb2-related 
adaptor protein and protein kinase C. 
 
Yanase et al. (2007a) investigated the relationship between the area of cell adhesion to a 
gold sensor chip and the change of SPR angle using SPR technique. RBL-2H3 rat mast 
cells and PAM212 mouse keratinocytes were cultured directly on the gold sensor chips. 
The results showed that the shift of the SPR angle was proportional to the cell density of 
non-stimulated cells on the gold sensor chip. The cells were stimulated with either 
antigen or epidermal growth factor causing great changes in the SPR angle with both 
compounds. However, the results were not consistent with the studied relationship 
between the change of SPR angle and adherent cell number. Based on the SPR results 
and microscopic visualization, it was suggested that the change in the SPR angle 
induced by extracellular stimuli reflects intracellular events rather than changes in the 
size of the area where cells adhere. 
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Later in 2007, Yanase et al. (2007b) demonstrated that SPR can also detect the reactions 
of non-adherent cells, including human basophils and lymphocytes, by fixing them to 
the gold sensor chip. Three types of fixing methods were tested, a biocompatible anchor 
for cell membranes, aminoalkanethiol and an amino-reactive cross-linker. All three 
methods were capable of fixing cells on the gold sensor chip. The study showed that 
SPR was able to detect cell activation in spheroid cells, when cells were stimulated with 
antigens. The activation was observed as a change in the SPR angle. This indicates that 
the SPR technique may be a useful tool for the analysis of clinically important cell 
functions, such as basophil histamine-release, and lymphocyte stimulation.  
 
In 2010, a new method was introduced for the evaluation of G protein-coupled receptor 
(GPCR) activation utilizing the SPR technique (Chen et al. 2010). Chinese hamster 
ovary (CHO)-K1 cells expressing GPCRs were cultured directly on a gold sensor chip 
and stimulated with GPCR ligands. They succeeded in monitoring GPCR-mediated 
cellular responses in cells by using SPR. The results suggest that the GPCR-mediated 
actin rearrangement in the cellular cortex in the evanescent field is reflected in the SPR 
responses. The study indicates that the SPR analysis may be useful in ligand/drug 
discovery for certain types of receptors when cytoskeletal rearrangements are involved.  
 
Moreover, Lee and his group (2006) have applied SPR to study interactions between 
ligand and GPCRs using living cells. HEK-293 cells expressing olfactory receptors 
(ODR-10) on the cell surface were cultured on a poly-D-lysine coated gold sensor chip. 
When the cells were exposed to known specific receptor-agonist, it resulted in an SPR 
angle change in a dose-dependent manner. The cells without ORD-1 receptors did not 
show any response in the SPR angle. The activation of the cells expressing the receptor 
by the agonist induced an increase in the intracellular Ca2+ ions, which resulted in a 
change in the SPR angle. The supposed increase of intracellular Ca2+ was confirmed by 
measuring the cytosolic Ca2+ ions. 
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4.4.2 Toxicity and morphological changes 
 
Chabot et al. (2009) showed that the SPR technique could be applied to study a large 
variety of cellular responses involving to shape remodeling induced by external agents. 
Human embryonic kidney-293 (HEK-293) cells were grown on a gold sensor chip. The 
immobilized cells were monitored when the cells were stimulated with three types of 
stimuli: a bacterial endotoxin (lipopolysaccharides), a chemical toxin (sodium azide) 
and a physiological agonist (thrombin). The fixed angle intensity decreased after 
stimulation of lipopolysaccharides and an increase in the concentration lead to an 
increase in the magnitude of the measured SPR response. The result was confirmed by 
phase contrast micrographs, which indicated a collapse of the intracellular structure 
after 30 min of stimulation. Stimulation with sodium azide also decreased the measured 
signal and micrographs showed an increase in the size of the intracellular space as a 
result of cell shrinkage. When cells were stimulated with thrombin, the SPR signal was 
first decreasing followed by a slower recovery back to the baseline. Microscopic 
observations confirmed that this was due to cell contraction followed by with 
respreading of the cells. The results showed that SPR can be used to monitor real-time 
morphological changes in the cells induced by chemical or biological agents. The study 
demonstrated the possibility to utilize SPR biosensor for environmental and health care 
applications to determine the presence of toxins and their corresponding cellular 
responses and in pharmacological studies to better understand cell signaling pathways 
activated by pharmacological agents.  
 
Cuerrier and coworkers (2008) also applied the SPR technique to study morphological 
changes in living cells induced by an external agent. They used SPR to quantify the 
cellular activity of an epithelial cell monolayer stimulated by angiotensin II. HEK-293 
cells, stably expressing the angiotensin II AT1 receptor, were cultured on the gold 
sensor chip. Immediately after the stimulation by angiotensin II, a rapid decrease in the 
fixed angle intensity was observed about 2 min after stimulation followed by an 
increase in the fixed angle intensity that gradually exceeded the baseline value. The 
same response was not observed, when cells were pretreated with AT1 receptor 
antagonist. Microscopic visualization revealed that after 2 min after the cell stimulation 
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with angiotensin II, a contraction of the cell body was clearly visible with an increase in 
the intercellular spaces compared to the observations before analysis. This initial cell 
response was followed by a spreading of the cells and a decrease of the intercellular 
spaces. Confocal micrographs revealed a temporal redistribution of actin after 
angiotensin II stimulation, which was also found to be consistent with the SPR signal 
variation. The study demonstrates that morphological changes in a human epithelial cell 
monolayer can be followed in real-time using the SPR technique.  
 
Recently, the interaction between monoclonal antibody EGFR1 and membrane protein 
epidermal growth factor receptor (EGFR) on human gastric cancer BGC823 cells has 
been studied using the SPR technique (Liu et al. 2011). When immobilized cells were 
stimulated with EGFR1, the fixed angle intensity first shifted to a higher value and later 
declined gradually. Microscopic visualization revealed that after the stimulation the 
shapes of most cells changed from fusiform to round confirming that EGFR1 causes 
changes in cells’ morphology. It was observed that the higher the concentration of 
EGFR1, the greater the fraction of rounded cells and the higher the decrease in the 
observed reflection intensity. The results proposed that EGFR1 might lead to the 
cytoskeletal rearrangements, reduce cells’ adhesion forces, and influence living 
BGC823 cells’ survival properties. This study also demonstrated that the SPR technique 
is capable of real-time detection of molecular interactions and cellular responses in 
living cells. 
 
SPR has also been applied to detect volume changes in cells which are directly grown 
on the gold sensor chip (Robelek and Wegener 2010). MDCKII cells were grown as a 
confluent monolayer on the surface. When a hypertonic buffer was flowed over the 
cells, it was observed that a rapid increase in the fixed angle intensity took place, while 
a hypotonic buffer decreased the signal. It was assumed that the stimulation with the 
hypertonic buffer increased the signal because of the loss of cellular water from the 
cytosol causing an increased cytoplasmic concentration of intracellular osmolytes which 
increased a refractive index in the evanescent field. Recently, Baumgarten and Robelek 
(2011) studied the volume responses of two renal epithelial cell types to non-isotonic 
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challenges with SPR. These studies showed that the SPR approach might be extended to 
a platform technology to screen for the therapeutic modulators of cell volume changes.  
 
4.4.3 The cell surface binding 
 
SPR analysis has been used to study the structure-activity relationship between major 
green tea catechins and their corresponding epimers (Fujimura et al. 2008). The cell-
surface binding of catechins to the cell surface and 67 kDa laminin receptor (67LR) was 
observed by SPR. Basophilic KU812 cells were immobilized on the surface of the SPR 
sensor chip and the cell-surface binding of eight kinds of tea catechins was studied. 
Differences in the fixed angle intensity were observed when galloylated catechins were 
bound to the surface of KU812 cells, but their non-galloylated forms did not induce any 
signal changes. The binding strengths of catechins in the SPR analysis suggested which 
functional groups are essential for the cell surface-binding of the catechins. Involvement 
of the 67LR in the cell-surface binding of galloylated catechins was studied with 67LR-
downregulated KU812 cells. The SPR measurement revealed that the cell-surface 
binding of all galloylated catechins was inhibited by the knockdown of 67LR 
expression. These patterns were also observed in the inhibitory effects of histamine 
release in a fluorometric assay. The results indicate that SPR analysis may be suitable 
for cell studies in order to study the binding of compounds to the cell surface or to 
specific cell surface receptors.  
 
 
6 CONCLUSIONS 
 
The permeability of a drug is crucial for the absorption and distribution of the drug. The 
oral delivery is the main administration route of drugs. Therefore various in vitro and in 
silico permeability assays have been developed and applied in the early phases of drug 
discovery and development process to predict intestinal absorption. The aim is to 
identify the pharmacologically active drug candidates which have the most promising 
ADME properties for the lead optimization and finally for clinical trials. However, 
traditional in vitro cell assays are often static, time-consuming, laborious, and suffer 
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from the influence of the unstrirred water layer thickness, which reduces the 
predictability of in vivo permeability especially for lipophilic compounds. Other in vitro 
assays e.g. PAMPA and in silico methods are suitable for high-throughput screening but 
these techniques only predict passive absorption, and do not take account other possible 
routes, e.g. paracellular or active transport.  
 
SPR is a non-invasive optical technique, which does not require labeling agents. In 
addition, it is a highly sensitive method enabling real-time monitoring of reactions in 
the immediate vicinity of a sensor surface. SPR technique is suitable for semi high-
throughput screening and only low amount of compounds is needed. Several studies 
have demonstrated that SPR may be beneficial for the study of the permeability of drugs 
in the early phases of drug discovery but so far the intestinal permeability has been 
predicted with SPR by liposome-based in vitro systems to study passive absorption. 
However, SPR has also been applied in the cell-based assays, where cells are 
immobilized directly on the sensor surface. Several studies indicate that it is possible to 
monitor real-time intracellular reactions induced by external agents by SPR. These 
studies suggest that SPR may be utilized for the prediction of ADME properties, e.g. the 
intestinal absorption of drug candidates. Depending on the cell line immobilized on the 
sensor surface, not only passive but also the active transport of compounds may be 
studied. The SPR cell-based method could be beneficial to be used along with other in 
vitro methods in order to predict intestinal drug absorption in the lead optimization 
phases of drug discovery, because it provides complementary data for traditional assays 
which could help in a better mechanistic understanding of drug absorption and drug-cell 
interactions. However, although SPR seems like a promising tool for drug absorption 
and drug-cell interactions studies, it is good to keep in mind that the phenomena 
detected by SPR are often very complex processes that might be difficult to interpret. 
Therefore, it is foreseen that a thorough validation of the SPR approach for drug 
absorption and drug-cell interaction studies against traditional assay is needed before it 
possibly will be widely accepted by pharmaceutical scientists for pharmaceutical 
research.  
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1 INTRODUCTION 
 
There is a strong need for new complementary in vitro methodologies for preclinical 
phases of the drug discovery and development process. The aim is to speed up the drug 
development process, to build a better understanding of drug absorption and drug-cell 
interactions, and to find, develop and optimize different administration routes. This is 
true, particularly in the case of nanoparticle mediated and liposomal drug delivery. 
Especially, the ability of examining living cells in their native and physiological 
relevant environments is crucial in order to improve the mechanistic understanding 
during drug discovery and development. Although cell-based assays are less specific 
and more complex than biochemical assays, cell-based assays give functional 
information that would otherwise be lost with biochemical assays. However, traditional 
in vitro cell assays, which are widely applied during preclinical phases, are laborious 
and static. Moreover, most of those assays measure a specific cellular event and the 
labeling of the ligand or target with a fluorescent compound is needed for imaging or 
detection purposes. Thus, the optical biosensors may offer a potential cell-based assay 
that can provide noninvasive and continuous data from cellular activity with high 
sensitivity.  
 
For the past 20 years, optical biosensors have been almost merely applied for routine 
biomolecular interaction analysis because of their capabilities to provide detailed 
information on the binding affinity and kinetics of an interaction (Rich and Myszka. 
2010; De Crescenzo et al. 2008). In particular, the ability to directly detect the binding 
of small molecules to immobilized receptors has widely increased the utility of optical 
biosensors in drug screening (Hämäläinen et al. 2000). Recently, optical biosensors 
have also been applied for cell-based assays because optical biosensors can screen and 
characterize a wide variety of cellular activity in native cellular environments without 
labeling (Fang 2011). Label-free cell-based assays based on an optical biosensor 
detection may have the potential to be utilized in many phases during the drug 
development process, including hit selection and optimization, screening of the 
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absorption, distribution, metabolism, excretion and toxicity (ADME/Tox) properties of 
drug candidates.  
 
Among the label-free techniques developed for probing the activities and interactions of 
living cells, the surface plasmon resonance (SPR) technique has been widely used. SPR 
is a non-invasive optical detection technique that does not require labeling agents 
(Kooyman 2008). Moreover, SPR is a highly surface sensitive method and it enables 
real-time monitoring. The SPR technique is based on surface plasmons which are 
longitudinal charge density waves occurring at the interface between a thin metal film 
such as gold or silver and the surrounding medium. The evanescent filed of the surface 
plasmon extends approximately 300 nm into the surrounding medium meaning that only 
the basal portion of the cell layer is sensed by the SPR technique. However, several 
studies have demonstrated that SPR is a powerful tool in real-time and non-labeled 
monitoring of living cells for studying diverse arrays of cellular processes (Yanase et al. 
2007; Fujimura et al. 2008; Chabot et al. 2009). The detection in these cell-based assays 
is based on the knowledge that cellular activation with an external agent often results in 
cellular reorganization, such as mass distribution, cell contraction and spreading, which 
affects the basal portion of the immobilized cells within the evanescent field. 
 
 
2 AIM OF THE STUDY 
 
The aim of this study was to evaluate the suitability of the SPR technique for cell-based 
studies to monitor drug-cell interactions in native cellular environments. SPR 
spectroscopy is an optical method which measures the change in the refractive index at 
the gold surface (Kooyman 2008). Briefly, when a compound adsorbs or binds to the 
gold sensor chip, the local refractive index changes leads to a change in the SPR angle 
which can be monitored in real-time. The size of the change in the SPR signal is directly 
proportional to the mass of the compound adsorbed or immobilized onto the gold sensor 
chip surface. The aim of this study was to immobilize cells either directly on the gold 
sensor chips or on the roof of the flow channel (Figure 1). When cells are immobilized 
directly on the gold sensor chip, the refractive index was expected to change as a result 
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of drug-cell interactions on the sensing surface leading to a change in the SPR angle. 
The second approach considered the possibility to measure the amount of test 
compound that is disappearing from the surrounding liquid when the test compound 
interacts with or is absorbed by the cells immobilized on the roof of the flow channel.  
 
 
Figure 1. The principle of SPR detection using the conventional Kretschmann optical 
configuration. SPR detects changes in the refractive index in the immediate vicinity of 
the sensor surface. It appears as a sharp dip in the reflected light from the surface at an 
angle that is dependent on the mass of molecules on the surface (left bottom image). 
The SPR angle shifts when molecules bind to the surface and mass on the surface is 
changed. The change can be monitored by plotting the resonance signal versus time 
which forms sensorgram (right bottom image) (Edited from Cooper 2002).   
 
 
The sensor chip and the roof of the flow channel have been made from different 
materials. The sensor chip is plated with gold and the roof of the flow channel is molded 
from poly-dimethylsiloxane (PDMS). Therefore, this study included the optimization of 
the immobilization conditions of cells on both of these two materials. Two cell lines, 
ARPE-19 and MDCKII cells were chosen for this work. The goal was first to grow cells 
confluent on these materials for SPR measurements. Finally, the SPR instrument was 
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used to probe the interaction of living cells with various test compounds, i.e. 
propranolol, D-mannitol, D-glucose and HSPC:Chol liposomes. For this purpose it was 
necessary to first optimize and choose the most convenient immobilization protocol for 
ARPE-19 and MDCKII cells, where after the aim was to determine if the test 
compounds show differences in the SPR signals upon interaction with ARPE-19 and 
MDCKII cells. Similar studies for ARPE-19 and MDCKII cells have not been done 
before. 
 
 
3 MATERIALS AND METHODS 
 
3.1 Cell culture 
 
Human retinal pigment epithelial (ARPE-19) cells and Madin-Darby canine kidney 
(MDCKII) cells were used in the studies. ARPE-19 cells (passage numbers 21-35) were 
grown in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (D-MEM/F-12, 
Gibco) supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 1 % 
Penicillin-Streptomycin solution and 2 mM L-Glutamine in an incubator (37 °C, 7 % 
CO2). MDCKII cells (passage numbers 15-29) were cultured in Dulbecco's Modified 
Eagle Medium (D-MEM) (Gibco) supplemented with 10 % heat-inactivated FBS and 1 
% penicillin-streptomycin solution. Cells were maintained at 37 °C in a 5 % CO2 
incubator. MDCKII cells were divided twice a week, while ARPE-19 cells were divided 
at one week intervals and growth medium was changed twice a week. 
 
3.2 Immobilization of cells on the flow channel of SPR biosensor 
 
3.2.1 Preparation of PDMS substrates 
 
The flow channel of the SPR instrument is covered with PDMS. The aim was to 
immobilize the cells on the flow channel which is illustrated in Figure 2. The PDMS 
substrates were molded to optimize the immobilization of the cells on the material and 
on the flow channel. The substrates were generated by using Sylgard 184 manufactured 
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by Dow Corning. Sylgard 184 contains two parts: an elastomer and a curing agent that 
were mixed in a ratio of 10:1 by weight. The elastomer and the curing agent undergo a 
hydrosilylation reaction upon cross-linking. After mixing, PDMS was allowed to cure 
for two days at room temperature. The PDMS substrates were sterilized by immersing 
them in 70 % ethanol solution overnight as described by Wang et al. (2010) and Lee et 
al. (2004). Hereafter, the substrates were washed 2 times with DPBS (Gibco) to remove 
the ethanol before further modification treatment and cell culture. The optimization was 
first performed on a 24-well polystyrene cell plate covered with PDMS. After the 
conditions were defined, the cells were seeded on the molded flow channel. This flow 
channel was prepared by casting the PDMS mixture into the mold of the flow channel 
of the SPR instrument. 
 
 
Figure 2. The dimensions (mm) of the flow channel in the SPR instrument. 
 
 
3.2.2 Modification of PDMS substrates 
 
The PDMS substrates were treated with a cell adhesion promoter in order to facilitate 
cell attachment on the hydrophobic PDMS surface. Several cell adhesion promoters 
were tested to determine the optimal component for the cell culture. PDMS substrates 
were rendered positively charged by treating with poly-L-lysine (PLL, Sigma-Aldrich) 
and with extracellular matrix (ECM) components, including fibronectin from human 
plasma (Sigma-Aldrich), laminin from Engelbreth-Holm-Swarm mouse tumor (BD 
Bioscience) or collagen type I from rat tail tendons (Trevigen). 
 
The optimal concentration for each cell adhesion promoter was determined by screening 
a range of different concentrations. Table 1 shows the concentrations tested during the 
optimization of the cell attachment on the PDMS substrates. According to the 
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manufacturer’s instructions each of the cell adhesion promoters were dissolved in the 
appropriate medium: PLL in tissue culture grade water, fibronectin in DPBS, laminin in 
serum-free cell culture medium and collagen I in 0,02 M acetic acid. Each PDMS 
surface was covered evenly with a minimal volume of the cell adhesion promoter 
solutions. The solutions were allowed to be in contact with the PDMS substrates for 1 h 
at room temperature, except for the type I collagen solution, which was kept at 37 °C.  
The solutions were then removed by aspiration. The substrates were rinsed twice with 
DPBS and allowed to dry for approximately 2 h at room temperature, where after the 
cells were seeded on the PDMS substrates treated with the cell adhesion promoters.  
 
Table 1. Cell adhesion promoters and concentrations tested for modification of PDMS 
substrates.   
Cell adhesion promoter Tested concentration 
Poly-L-lysine 25 µg/ml 100 µg/ml 
Fibronectin 15 µg/ml 30 µg/ml 
Laminin  33 µg/ml 67 µg/ml 
Collagen I 30 µg/ml 50 µg/ml 
 
 
3.2.3 Culturing of ARPE-19 cells on PDMS substrates 
 
ARPE-19 cells were cultured on both treated and non-treated PDMS substrates. The 
protocol described in section 3.2.2 was used to treat the PDMS substrates. ARPE-19 
cells were seeded at a density of 1,2 $ 105 cells/well (24-well plate). ARPE-19 cells 
were also seeded on the flow channel (Figure 2) of molded PDMS substrates treated 
with fibronectin (15 µg/ml). Only 15 µl of cell suspension could be used for cell seeding 
on the flow channel due to the small volume of the flow channel. Because of this, the 
cell seeding density also needed to be optimized. The tested seeding density was from 3 
200 to 50 000 cells/flow channel. The cells were allowed to attach and grow on the 
PDMS substrates or the flow channel for one to three days in the cell culture incubator. 
Since PDMS is transparent, the attachment of the cells on the PDMS substrates was 
easily observed by using an inverted microscope (Olympus CKX31). 
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3.3 Culturing of cells on surface plasmon resonance gold sensor chips 
 
SPR gold sensor chips (12 $ 20 mm) were obtained from Bionavis Ltd (Tampere, 
Finland). The thickness of the gold layer was ~48 nm on ~2 nm thick layer of a 
chromium adhesion layer on a glass slide. The gold sensor chips were thoroughly 
cleaned before the experiments to remove all the contaminants on the gold surface and 
reduce any optical disturbance on the glass side. The cleaning solution consisted of 1 
part of 30% ammonia hydroxide solution (Sigma) and 1 part of 30 % hydrogen peroxide 
(Sigma) in 5 parts Milli-Q-water. The gold sensor chips were boiled in the solution for 5 
min, followed by rinsing thoroughly with Milli-Q-water and dried with nitrogen. 
Finally, the gold sensor chips were autoclaved before cell immobilization. 
 
3.3.1 Modification of gold sensor chips 
 
Prior to cell culture, the gold sensor chips were first treated with cell adhesion 
promoters in order to observe, if the cells would adhere better on treated gold sensor 
chips. The gold sensor chips were treated with 100 µg/ml PLL in tissue culture grade 
water (Sigma-Aldrich) or 15 µg/ml fibronectin in DPBS (Sigma-Aldrich). First, the 
autoclaved gold sensor chips were rinsed twice with DPBS. Then, the gold sensor chips 
were covered with a minimal volume of PLL or fibronectin solution and incubated for 1 
h at room temperature. The cell adhesion promoter solutions were then removed by 
aspiration and the gold sensor chips treated with PLL were rinsed twice with DPBS. 
The treated gold sensor chips were then allowed to dry for 2 h at room temperature 
before cells were seeded. 
 
3.3.2 Immobilization of cells on gold sensor chips  
 
ARPE-19 and MDCKII cells were cultured on both treated and non-treated gold sensor 
chips. First, confluent cell monolayers in cell culture flasks were treated with 0,25 % 
trypsin/EDTA in DPBS, where after the cells were re-suspended in the cell culture 
medium. The gold sensor chip was then placed in a cell culture polystyrene petri dish 
with a cell growth area of 8,8 cm2 and 3 ml of the cell suspension was pipetted on the 
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gold sensor chip. The cells were allowed to attach and grow in the incubator until they 
were confluent. Seeding density (from 5 $ 105 to 8,8 $ 105 cells/petri dish) and days 
post-seeding (from one to four days) were optimized to determine the best conditions 
for the cells to attach to the gold sensor chips. This procedure was simultaneously done 
on several gold sensor chips. The sensor chips were observed through a microscope to 
assess the cell monolayer confluence and to ensure the reproducibility of the cell 
culturing protocol and consequently the SPR measurements. 
 
3.4 Viability of cells on PDMS substrates and gold sensor chips 
 
3.4.1 Trypan blue test 
 
The trypan blue test was performed to ensure the viability of cells cultured both on the 
PDMS substrates and the gold sensor chips. Cells cultured on tissue culture treated 
polystyrene wells were used as reference. After one or two days of culture, the medium 
was carefully removed and the cells were washed with DPBS before detaching with 
0,25% trypsin/EDTA solution. The cells were re-suspended in the cell culture medium, 
then trypan blue solution (Gibco) was added in a ratio of 1:1 (v/v) in order to stain the 
dead cells blue. The cell concentration and cell viability was determined with a Cedex 
XS cell counter (Roche Diagnostics Oy). 
 
3.4.2 MTT assay 
 
The MTT assay was performed in order to determinate the viability of the cells cultured 
on the gold sensor chips. Non-treated cells grown on standard polystyrene well plate 
were used as a positive control (100% viability), whereas cells treated with Triton-X 2 
% (Fluka) served as a negative control (0% viability). The MTT assays were performed 
two days post-seeding in the case of ARPE-19 cells, and three days post-seeding in the 
case of MDCKII cells. First, the cells were washed with DPBS, followed by addition of 
the MTT solution (5 mg/ml in DPBS, Sigma), and then incubating them at 37 °C for 2 
h. The formazan crystals formed were dissolved by adding SDS-DMF solution (20% 
SDS (Bio-Rad) in DMF, Fluka) at pH 4.7 (adjusted with 80% acetic acid : 1 M HCl 1:1 
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by volume). Cell culture plates were then incubated overnight at 37 °C to allow 
complete dissolution of the formazan crystals. The amount of formazan was determined 
colorimetrically at a wavelength of 595 nm using a spectral scanning multimode reader 
Varioskan (Varioskan Flash 2.4.3. Thermo Scientific). 
 
3.5 Flow experiments with the immobilizer 
 
The SPR instrument used in this work has a flow channel system consisting of two 
separate flow channels, which are operated by the same peristaltic pump. The liquid 
flowing in the flow channels is in direct contact with the gold sensor chip and the height 
of the flow channel is 100 µm. An equipment called “the immobilizer” (Figure 3), 
compatible with the gold sensor chips and the slide holder of the instrument, was used 
to study how ARPE-19 and MDCKII cells resisted the shear stress induced by the liquid 
flow. The immobilizer is composed of a plain flow system without peristaltic pump 
thus, an external syringe pump was used (SPR Navi 200 syringe pump –module) for 
these studies. The height of the flow channel in the immobilizer is 300 µm. The flow 
experiments were performed by flowing the buffer, Hank’s Balanced Salt Solution 
(HBSS, Gibco) supplemented with 10 mM Hepes (Sigma-Aldrich) at pH 7,4 (adjusted 
with 1 M NaOH) at flow rates from 5 to 120 µl/min. The effect of the flow was 
observed for 15 min to 3 h at room temperature to investigate how long the cells stayed 
attached to the gold sensor chip under constant flow. After the cells were exposed to the 
flow they were observed by an optical microscope.  
 
Figure 3. Schematic picture of the immobilizer without an external peristaltic pump. 
The numbered parts are: (1) gold sensor chip and (2) flow channel (Edited from Liang 
et al. 2010)   
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Because the height of the flow channel is not the same in the immobilizer and the SPR 
instrument, it was necessary to use different flow rates in the immobilizer and the SPR 
instrument in order to make sure that the flow conditions were comparable with each 
other. The shear stress on the sensor surface induced by the liquid flow is taken as a 
measure for the hydrodynamic conditions in the flow channel and it is dependent on the 
dimensions and the footprint of the flow channel (Viitala et al. 2012). The shear stress 
in the flow channel with the same footprint is given by the following equation: 
! 
S = f "
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where S is shear stress, f the flow rate and h the height of the flow channel. The 
conversion factor for the flow speed giving the same hydrodynamic conditions in the 
flow channel of the immobilizer and the SPR instrument can be obtained by substituting 
the heights of the immobilizer (300 µm) and the flow channel in the SPR instrument 
(100 µm) into equation 1. 
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The above calculation reveals that the flow rate had to be nine times higher in the 
immobilizer than in the SPR instrument in order to obtain comparable shear stresses in 
both equipments.  
 
3.6 Test compounds in surface plasmon resonance analysis 
 
Propranolol hydrocholoride (Sigma-Aldrich), D-mannitol (Fluka), D-glucose 
monohydrate (Riedel-de Haen) and liposomes consisting of fully hydrogenated soy 
phosphatidylcholine (HSPC, Avanti Polar Lipids) and cholesterol (chol, Avanti Polar 
Lipids) were used as test compounds in the SPR interaction studies with living cells. 
Each test compound was diluted in a buffer composed of HBSS supplemented with 10 
mM Hepes (Sigma) and adjusted to pH 7,4 with 1 M NaOH. HSPC:Chol liposomes 
with the molar ratio 2:1 were prepared using the traditional extrusion technique. The 
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liposomes were diluted in HBSS buffer to a HSPC concentration of 1 mM. All test 
solutions were sonicated before the SPR measurement to minimize the formation of air 
bubbles during the measurement. 
 
 
3.7 Surface plasmon resonance analysis 
 
Interaction experiments between each test compound and immobilized cells were 
performed using the SPR Navi 200 instrument (Bionavis Ltd, Tampere, Finland). The 
cells were cultured on the gold sensor chip for three to four days before analysis. Prior 
to the measurement, the whole flow path of the SPR instrument was filled with the 
running buffer HBSS. Once the cells were confluent on the gold sensor chip, the cells 
were washed once with the buffer and the gold sensor chip was quickly inserted into the 
slide holder using tweezers. Hereafter, the glass side of the sensor chip was cleaned 
with 70 % ethanol to remove any optical disturbances from the surface and the slide 
holder was then inserted in the instrument. 
 
The SPR experiments were performed under constant flow using a syringe pump 
accessory (SPR Navi 200 syringe pump –module) at a flow rate of 5 µl/min for ARPE-
19 cells, and at a flow rate of 10 µl/min for MDCKII cells. The interaction between 
cells and test compounds were measured by injecting the compound of interest for 6-10 
min followed by a rinsing period of 6-10 min with the buffer. The samples were 
injected manually with a syringe to two sample loops through an injection port in a 
series of increasing concentrations. The sample loops were flushed with the buffer after 
every sample injection to avoid any carryover effect. All the experiments were 
performed at 20 °C by using the angular scan mode. The angular scan mode measures 
the change of the SPR peak minimum angular position (the SPR angle) in a selected 
angular scan range. In these experiments the selected angular scan range was at least 60 
- 78°, which provided the full SPR angular spectra every 4th second. The full SPR 
angular spectra means that not only the change in the SPR peak minimum angular 
position but also e.g. the change in the SPR peak minimum intensity can be measured. 
At the end of each experiment, the SPR sensor slide was observed under an optical 
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microscope in order to evaluate the cell monolayer integrity after the interaction 
experiments. 
 
3.8 Data handling 
 
A widely accepted simplification for the measured SPR signal is that the change in the 
SPR peak minimum position (angle or wavelength) or fixed angle intensity is linearly 
proportional to the mass change in the evanescent field. The experiments in this work 
were performed using the angular scan mode, which monitors the change in the SPR 
angle in real-time. Briefly, the SPR instrument monitors the change of the refractive 
index on the surface of gold sensor chip which is reflected as a change in the SPR angle. 
The angular change is plotted in a sensorgram which shows the change in the SPR angle 
in real-time. Figure 4 illustrates the steps of a simple biomolecular interaction SPR 
analysis. Furthermore, the SPR instrument used in this work also provides other 
information than the angular change information. For example, it is also possible to 
observe the change in the SPR peak minimum intensity during the measurements. The 
SPR angle and/or the SPR peak minimum intensity is expected to change in SPR 
measurements with immobilized cells which is caused by changes in the reflectance 
properties of the cell monolayer due to morphological changes induced by exogenous 
stimulation. 
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Figure 4. Sensorgram showing the steps of a simple SPR measurement where a receptor 
is immobilized on the gold sensor chip. 1) A buffer is contacted with the receptor 
through a flow channel. 2) Continuous injection of a solution of an analyte in the buffer. 
When the analyte binds to the receptor, then the refractive index in the near vicinity of 
the sensor surface increases leading to an increase in the SPR angle. 3) Injection of 
buffer on the gold sensor chip flushes off the non-specifically bound components. %R 
indicates the angular change caused by the bound analyte. 4) A regeneration solution is 
injected, which breaks the specific binding between the analyte and the receptor (Tudos 
and Schasfoort 2008). 
 
 
4 RESULTS 
 
4.1 Attachment and proliferation of ARPE-19 cells on PDMS substrates 
 
ARPE-19 cells were cultured on PDMS to observe if the cells can be grown on the 
PDMS flow channel of the SPR instrument. In this approach the objective was to grow 
the cells as a confluent monolayer on the flow channel of the SPR instrument, and then 
probe the interaction between the cells and the test compounds in order to measure the 
amount of test compound that is disappearing from the surrounding liquid because of 
the drug-cell interaction. Since the real PMDS flow channel has a very small area where 
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the cells can be seeded it was first necessary to optimize the immobilization of cells on 
PDMS molded in 24-well plates. Figure 5 shows the microscopy images of ARPE-19 
cells cultured on the PDMS substrates and in traditional polystyrene well plates. These 
microscopy images clearly show that the ARPE-19 cells did not adhere on non-treated 
PDMS substrates. The cells were floating in the cell culture medium and some of them 
just adhered to other cells without contacting the PDMS surface. These results indicate 
that PDMS with a common 10:1 elastomer to curing agent mixing ratio did not support 
the attachment of ARPE-19 cells.  
 
 
Figure 5. Light microscopy images of ARPE-19 cells cultured on A) non-treated PDMS 
substrate and (B) polystyrene well plate for one day. Magnification in images is 5x. 
Scale bar represent 200 µm. 
 
 
Because ARPE-19 cells did not adhere on non-treated PDMS, the modification of the 
PDMS substrates was required. The PDMS substrates were modified with poly-L-
lysine, fibronectin, laminin or type I collagen to promote cell adhesion and growth by 
physical adsorption of the cell adhesion promoter on the PDMS surface. These cell 
adhesion promoters were selected because they have been applied earlier for the same 
purpose by Wang et al. (2009). As illustrated in Figure 6, differences in the attachment 
and proliferation of ARPE-19 cells could be detected depending on the cell adhesion 
promoter used. From all the tested materials PDMS treated with fibronectin was found 
to support the attachment and proliferation of ARPE-19 cells to a similar extent as the 
polystyrene well plate, which was used as a control. In this case, cell confluence level 
was about 100% after two days of culture and the shape of the ARPE-19 cells was 
similar to the cells cultured on polystyrene. It was also found that 15 µg/ml fibronectin 
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enhanced the attachment of ARPE-19 cells to the same extent as the higher 
concentration of fibronectin (30 µg/ml). 
 
 
Figure 6. Growth of ARPE-19 cells after two days seeding on the PDMS substrates 
treated with different cell adhesion promoters: A) 25 and B) 100 µg/ml poly-L-lysine, 
C) 15 and D) 30 µg/ml fibronectin, E) 30 and F) 50 µg/ml type I collagen and G) 33 and 
H) 67 µg/ml laminin. The cells growing on a traditional polystyrene well plate were 
used as a control (I). Magnification in images is 5x. Scale bars represent 200 µm. 
 
 
In addition to the microscopic observations, the proliferation of ARPE-19 cells was 
determined with trypan blue test after one and three days of culture. The number of 
viable cells cultured on the treated PDMS substrates is illustrated in Figure 7. After 
three days, the number of living cells had increased for all ECM proteins, except for the 
type I collagen (30 µg/ml). Laminin enhaced the initial attachment of the cells on 
PDMS, but the proliferation was slower than on polystyrene. The modification with 
fibronectin had a significant effect on the number of living cells growing on PDMS. In 
this case, the proliferation of ARPE-19 cells was of the same as on polystyrene. 
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Moreover, the trypan blue test showed a cell viability of 98,7% (n=2) determined for the 
cells cultured on 15µg/ml fibronectin-treated PDMS for three days, which was basically 
the same as the cell viability of 98,6 % (n=2) on polystyrene. The proliferation of the 
cells on poly-L-lysine-treated PDMS was not determined because it did not promote the 
adhesion of ARPE-19 cells based on the microscopic observations (Figure 6A-B). 
 
 
Figure 7. Number of viable ARPE-19 cells cultured on the treated PDMS substrates 
modified with different ECM proteins: 30 (C1) and 50 µg/ml type I collagen (C2), 33 
(LN1) and 67 µg/ml laminin (LN2), and 15 (FN1) and 30 µg/ml fibronectin (FN2). The 
cells growing on polystyrene well plate were used as a control. The cells were counted 
one (n=1) and three days (n=2) post-seeding. 
 
 
These results show that ARPE-19 cells can be grown confluent and viable on the 
fibronectin-treated PDMS substrates. For this reason, fibronectin (15 µg/ml) was the 
cell adhesion promoter selected to treat the PDMS molded flow channel. However, the 
seeding of the cells on the fibronectin-treated PDMS molded flow channel was not 
straightforward because of the small volume of the flow channel. Therefore, only 15 µl 
of cell suspension could be used for the cell seeding on the PDMS molded flow 
channel. Moreover, the visualization of the immobilized ARPE-19 cells on the PDMS 
molded flow channel was rather challenging as illustrated in Figure 8. Different cell 
seeding densities were also tested because it was anticipated that successful SPR 
measurement would require confluent cell monolayers grown on the flow channel. 
However, it was not possible to select the optimal seeding density based on light 
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microscope visualization, because it was not possible to easily separate the cells from 
the surface of the PDMS molded flow channel by an optical microscope. Based on these 
results it was decided that no further attempts to grow cells on the PDMS flow channel 
in the SPR instrument would be made, and that it would be more important to 
concentrate on the second approach where cells would be directly immobilized on the 
gold sensor chips.  
 
 
Figure 8. ARPE-19 cells cultured on the flow channel molded from PDMS: A) 1 hour 
and B) 48 hours after seeding. Magnification in images is 5x. 
 
 
4.2 Growing and viability of the cells on gold sensor chip  
 
The immobilization of ARPE-19 and MDCKII cells on the gold sensor chips was 
optimized for the second approach of this work, where the objective was to culture the 
cells directly on the gold sensor chip. In this approach, the refractive index was 
expected to change as a result of drug-cell interactions on the sensing surface leading to 
a change in the SPR angle. In order to ensure the repeatability of the SPR measurements 
and to avoid unspecific adsorption of the test compounds on the bare gold surface, it 
was necessary to grow confluents cell monolayers in the middle of the gold sensor chip, 
where the change in the refractive index is measured. First, the growing of the cells was 
observed through a microscope to study if the cells grow confluent on the non-treated 
gold sensor chip, and if treatment of the gold sensor chip was needed in order to attach 
the cells to the surface. The cell spreading is generally assumed to give only an 
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indication of cell adhesion. Therefore, also the viability of the cells on the gold sensor 
chips was studied using both trypan blue test and the MTT assay.  
 
4.2.1 ARPE-19 cells 
 
ARPE-19 cells were cultured on non-treated gold sensor chips and gold sensor chips 
treated with poly-L-lysine (100 µg/ml) or with fibronectin (15 µg/ml). PLL was chosen 
because it is widely used to promote cellular adhesion to a surface by providing a 
polycationic layer on the substrate interacting with the polyanionic cell surfaces (Yavin 
and Yavin 1974). Moreover, PLL has earlier been utilized in SPR studies with cells by 
Chabot el al. (2009) in order to attach cells to a gold sensor chip. Fibronectin was 
selected because it is an ECM glycoprotein, which modulates the cell attachment by its 
arginine-glycine-aspartic acid cell adhesion peptides that adhere to the surface and 
interact with the cells (Rezania and Healy 1999).  
 
The cell adhesion and growth of ARPE-19 cells were followed during three days. 
Figure 9 shows microscopy images of cells that have adhered on the surface of the gold 
sensor chips after three days of culture. The attachment and proliferation of ARPE-19 
cells on non-treated and fibronectin-treated gold sensor chips was similar as on 
polystyrene. In these three different cases, cells were growing confluent on the surfaces 
but the treatment with PLL appeared to suppress the proliferation of the cells. Thus, the 
microscopic images indicated that the treatment of the gold sensor chips with an 
adhesion promoter was not needed to successfully immobilize a confluent ARPE-19 cell 
monolayer on the gold sensor chips.  
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Figure 9. Light microscopy images of ARPE-19 cells cultured for three days on A) gold 
sensor chip, B) gold sensor chip treated with fibronectin and C) with poly-L-lysine and 
D) polystyrene well plate. Magnification in images is 5x. 
 
 
The trypan blue and the MTT assay were performed to detect the viability of ARPE-19 
cells cultured on non-treated and fibronectin-treated gold sensor chips. According to the 
test results, the culturing on the gold sensor chips had no significant inhibitor effect on 
the cell viability after one and two days of culture (Figure 10). The trypan blue test 
showed that the viability of the cells on the gold sensor chip was similar as on 
polystyrene, which was used as a control (Figure 10A). Furthermore, the MTT assay 
confirmed that the culturing of ARPE-19 cells on the gold sensor chip did not decrease 
the viability of the cells after two days of culture (Figure 10B). The percentage of viable 
cells cultured on non-treated gold sensor chip was 111,3±10,3% and 105,6±11,1% on 
the fibronectin-treated gold sensor chips. 
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Figure 10. Viability of ARPE-19 cells cultured on non-treated gold sensor chips, gold 
sensor chips treated with fibronectin (15 µg/ml) and traditional polystyrene well plate 
(control) assessed by A) trypan blue and  B) MTT assay. The trypan blue test was 
performed one day and the MTT assay three days post-seeding. Reported values and 
standard errors are average of three parallel experiments. 
 
 
4.2.2 MDCKII cells 
 
MDCKII cells were cultured both on non-treated and fibronectin-treated (15 µg/ml) 
gold sensor chips. The growth of MDCKII cells on the gold sensor chips was followed 
during three days. Figure 11 shows microscopy images of cells that have adhered on the 
surface of the gold sensor chips after three days of culture. According to the 
microscopic observation it was clear that MDCKII cells also adhered on the surface of 
the non-treated gold sensor chips. The growth and attachment of MDCKII cells on the 
gold sensor chips were similar as on polystyrene. The microscopy images thus revealed 
that pre-treatment of the gold sensor chips with an adhesion promoter was not necessary 
to successfully immobilize a confluent MDCKII cell monolayer on the gold sensor 
chips. 
 
  
A B 
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Figure 11. Light microscope images of MDCKII cells cultured for three days on A) a 
non-treated gold sensor chip, B) gold sensor chip treated with 15 µg/ml fibronectin and 
C) polystyrene well plate. Magnification in images is 5x. 
 
 
However, the microscopy images revealed that MDCKII cells formed clusters when 
they were cultured fully confluent on the smooth non treated gold sensor chip surface. 
For this reason, the cell density needed to be carefully controlled. The seeding density 
was optimized so that the cells grew confluent with the lowest possible amount of the 
seeded cells (Figure 12). Based on the microscopic observations of different cell 
seeding densities it was found that the optimum seeding density that produced a cluster 
free confluent cell monolayer was 7 $ 104 cells/cm2 and this was selected for the further 
experiments.   
 
 
Figure 12. Light microscope images of MDCKII cells with different seeding density 
grown on non-treated gold sensor chips for three days. Cell seeding density: A) 5 $ 104 
cells/cm2, B) 7 $ 104 cells/cm2 and C) 1 $ 105 cells/cm2. 
 
 
According to the results of the trypan blue and the MTT assays, culturing the cells on a 
non-treated gold sensor chip surface did slightly decrease the viability of the MDCKII 
cells after one and three days of culture (Figure 13). According to the trypan blue assay, 
the percentage of viable cells seeded on non-treated gold sensor chip surfaces were 
90,4±3,5% and on polystyrene wells 92,6±2,2%. In the case of the MTT assay the mean 
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cell viability value obtained for cells cultured on non-treated gold sensor chips was 
81,5±8,9%, when the absorbance values obtained for cells cultured on polystyrene were 
accepted as 100±8,2%. 
 
 
 
Figure 13. Viability of MDCKII cells cultured on gold sensor chips: A) Trypan blue test 
and B) MTT assay. MDCKII cells cultured in polystyrene well plates were used as a 
control. The trypan blue test was performed one day and the MTT assay three days 
post-seeding. Reported values and standard errors are average of six parallel 
experiments. 
 
 
MDCKII cells were cultured only on the gold sensor chips and not on the PDMS 
substrates because it was difficult to visualize the cells on PDMS as shown in the case 
of ARPE-19 cells (Figure 8). Therefore, it was decided to perform all the drug-cell 
interaction measurements with SPR using the approach where the cells are immobilized 
directly on the gold sensor chip. This approach was chosen because both ARPE-19 and 
MDCKII cell lines were growing confluent and viable on non-treated gold sensor chips. 
Furthermore, the seeding process was significantly more straightforward than the 
immobilization of the cells on the flow channel of the SPR instrument. 
 
 
 
 
 
A B 
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4.3 Flow experiments 
 
As illustrated in Figure 14, the examination of the gold sensor chip under an optical 
microscope at the end of the first SPR measurement with ARPE-19 cells revealed that 
the cells had detached from the surface during the measurement. For this reason, flow 
experiments with the immobilizer were performed before actual SPR measurements. 
The aim was to study the resistance of ARPE-19 and MDCKII cells immobilized on the 
gold sensor chips to the surface shear force created by the flow of the running buffer in 
the flow channel of the SPR instrument. The immobilizer is a plain accessory which 
mimics the flow conditions in the SPR instrument. The objective was to define the flow 
rate of the buffer that can be applied in the SPR measurements so that the cells remain 
attached as a confluent cell monolayer on the gold sensor chip during the measurement.   
 
 
Figure 14. Light microscope images of ARPE-19 cells on a non-treated gold sensor chip 
A) before and B) after the SPR measurement with a flow rate of 20 µl/min of buffer at 
20 ºC. The cells were seeded one day before the measurement. In Figure B it can be 
seen how the cells have detached from the gold sensor chip. Magnification in images is 
5x. 
 
 
According to the results, the critical parameters identified to affect the attachment of the 
cells on the gold sensor chip during the SPR measurements were: cell line, cell density, 
days post-seeding and flow rate. The flow experiments indicated that ARPE-19 cells 
needed to be cultured at least two days before the SPR measurements were performed in 
order to attach the cells more strongly on the gold sensor chip surface. The examination 
under the microscope revealed that the treatment of the gold sensor chips with cell 
adhesion promoters was not needed, because ARPE-19 cells were attached even more 
confluent on a non-treated gold sensor chip compared to a fibronectin-treated gold 
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sensor chip after 3 hours of buffer flow at a flow rate of 5 !l/ml (Figure 15). As the 
ARPE-19 cells were detaching from the gold sensor chip at higher flow rates a flow rate 
of 5 µl/ml was decided to be used in the SPR measurements with ARPE-19 cells. 
 
 
Figure 15. Light microscope images of ARPE-19 cells on A) a non-treated and B) 
fibronectin-treated (15 µg/ml) gold sensor chip after exposed to a buffer flow rate of 5 
µl/min for three hours in the immobilizer. The cells were seeded two days before 
measurement. Magnification in images is 5x. 
 
 
MDCKII cells were perfused with a buffer at various flow rates ranging from 5 to 120 
"l/min. These flow experiments revealed that MDCKII cells can resist the flow-induced 
shear stress much better than ARPE-19 cells (Figure 16). Based on these results and as 
described by Robelek and Weger (2010), the flow rate of 10 "l/min was chosen for the 
SPR measurements with MDCKII cells. However, the examination under the 
microscope showed that MDCKII cells were attached as a confluent monolayer on a 
non-treated gold sensor chip even after being exposed to a flow rate of 120 "l/min for 
approximately two hours. This may be valuable information for future studies with 
MDCKII cells in SPR based cell assays. The flow experiments clearly demonstrate that 
there is no need for pre-treatment of the gold sensor chips with cell adhesion promoters 
before seeding the MDCKII cells on the gold sensor chip for SPR studies with varying 
flow rates. 
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Figure 16. Light microscope images of MDCKII cells immobilized on the non-treated 
gold sensor chips after the flow experiments with the immobilizer. The parameters 
shown are: flow rate of buffer (Q), time in flow (t) and hours post-seeding (c). The 
influence of the buffer flow on the attachment of the cells on the gold sensor chip was 
tested with the flow rates from 5 µl/min to 120 µl/min for 15 min to 3 h. The flow rate 
shown is equivalent to that in the SPR instrument. Magnification in images is 5x. 
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4.4 Drug-cell interaction analysis with surface plasmon resonance 
 
The successful immobilization of the cells as a confluent monolayer on the gold sensor 
chips was verified through microscopic observations before every SPR measurement. 
The SPR measurements were performed by using the angular scan mode which 
measures the SPR peak minimum angular position (the SPR angle) as a function of 
time. The first SPR measurement was performed by exposing ARPE-19 cells to a pure 
buffer at a flow rate of 5 µl/min for two hours. During the exposure to the pure buffer, a 
significant decrease in the SPR angle was observed (not shown). This decrease of the 
SPR angle indicated that ARPE-19 cells were detaching from the gold sensor chip in the 
buffer flow. Indeed, after the measurement, the gold sensor chip was visualized with a 
microscope and the cells had detached. Attempts to overcome the problems with this 
cell line in the SPR measurements were tried by changing the buffer, and further trying 
to optimize the cell immobilization protocol on the gold sensor chip. At first, the DPBS 
buffer was replaced by HBSS (10 mM HEPES, pH 7,4). Secondly, the cell seeding 
density was changed from 5,3 $ 104 to 8,7 $ 104 cells/cm2. Finally, the cell culturing 
time on the gold sensor chip was changed to three to four days instead of one day. Even, 
when the SPR measurement was performed with these optimized conditions, ARPE-19 
cells still detached from the surface. For this reason, the SPR measurements were 
continued only with MDCKII cells. 
 
MDCKII cells were exposed to the test compounds at a flow rate of 10 µl/min. Figure 
18A shows a typical sensorgram of the SPR angle during an experiment when a 
confluent MDCKII cell monolayer was exposed to an increasing concentrations of 
propranolol, i.e. 2,5; 25, 50 and 250 µM. The SPR angle was displaced to lower angles 
during the exposure, and when the cells were only rinsed with the pure buffer after the 
propranolol exposure the SPR angle was displaced to higher angles compared to the 
baseline. An increase in the SPR angle indicates that a certain fraction of propranolol 
remains in the cell monolayer after the exposure. The increase in the SPR angle was 
clearly concentration dependent. Surprisingly, when the cells were exposed to the 
highest concentration of propranolol the SPR angle shift was positive, which suggests 
that morphological changes occurred in the immobilized cells during the exposure 
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(Figure 18B). As illustrated in Figure 18C, no significant change in the SPR angle was 
observed when propranolol was interacting with a non-treated gold sensor chip without 
cells. This result confirms that the change in the SPR angle measured during the 
interaction of propranolol with the immobilized MDCKII cells actually reflects real 
drug-cell interactions and not drug-gold interactions.  
 
 
  
Figure 18. A) Measured changes in the SPR angle as a function of time when a 
MDCKII cell monolayer was exposed to propranolol (µM) for 10 min followed by 
rinsing with a pure buffer. Down arrows represent the time of sample injections, and up 
arrows the time of the injection of a pure buffer. B) Maximum measured change in the 
SPR angle when MDCKII cells were exposed to 2,5 (n=4); 25 (n=6), 50 (n=2) and 250 
µM (n=6) propranolol. The mean and standard errors of individual measurements are 
shown. C) Measured changes in the SPR angle as a function of time when propranolol 
was interacting with a non-treated gold sensor chip without cells. D) Maximum 
measured change in the SPR angle when the non-treated gold sensor chip without cells 
was exposed to propranolol (n=2). 
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Furthermore, when studying the measured full SPR angle spectra during the exposure of 
a MDCKII cell monolayer to propranolol there was a clear change in the SPR peak 
minimum intensity as illustrated in Figure 19. Exposing the cells to propranolol 
decreased the SPR peak minimum intensity from 0,0705 to 0,0689. After the exposure, 
when the immobilized cells were rinsed with pure buffer, the intensity was shifted to a 
higher intensity (0,0791). In biomolecular assays, an increase in the SPR peak minimum 
intensity indicates that the sample adsorbs or scatters the light used for SPR detection. 
Moreover, the SPR peak minimum intensity did not shift when the measurement was 
done on the non-treated gold sensor chip without the cells (data not shown). Therefore, 
these results strongly suggest that the observed change in the SPR peak minimum 
intensity during propranolol interaction causes intracellular changes in the immobilized 
cells. 
 
 
Figure 19. Focused part of full SPR angular spectra illustrating the change in the SPR 
peak minimum intensity of the SPR curve in the presence of MDCKII cells in a buffer 
flow before the exposure (black), during the exposure to 2,5 µM propranolol (red) and 
after the exposure in a buffer flow (blue). 
 
 
In addition to propranolol, MDCKII cells were also exposed to an increasing 
concentration of D-mannitol. Figure 20A shows that the exposure of the cells to 0,0025; 
0,025; 0,25; 2,5; 25 and 250 µM D-mannitol always caused a decrease in the SPR 
angle. This result indicates that even though D-mannitol diffuses poorly into the cells, 
some changes in the cell monolayer occurred during D-mannitol exposure. Figure 20B 
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illustrates the effect of D-mannitol injections on the SPR angle shift showing that the 
SPR angle shift was almost constant at every tested concentration, and no concentration 
dependency was observed. When the MDCKII cell monolayer was exposed to the pure 
buffer after each injection of D-mannitol, the SPR angle always returned to the baseline 
level. This result suggests that D-mannitol did not diffused into the immobilized cells or 
it was almost completely removed from the cell monolayer after the exposure regardless 
of the concentration used. Figure 20C and 20D also show that no significant change in 
the SPR angle was measured when D-mannitol was interacting with a non-treated gold 
sensor chip without cells.  
 
 
 
Figure 20. A) Measured changes in the SPR angle as a function of time when a 
MDCKII cell monolayer was exposed to D-mannitol (µM) for 7 min. Down arrows 
represent the time of sample injections, and up arrows the time of the injection of a pure 
buffer. B) Maximum measured change in the SPR angle when MDCKII cells were 
exposed to 0,0025 (n=3); 0,025 (n=6); 0,25 (n=6); 2,5 (n=8); 25 (n=6) and 250 µM 
(n=4) D-mannitol. The mean and standard errors of individual measurements are 
represented. C) Measured changes in the SPR angle as a function of time when D-
mannitol was interacting with a non-treated gold sensor chip without cells. D) 
Maximum measured change in the SPR angle when a non-treated gold sensor chip 
without cells was exposed to D-mannitol (n=1). 
A B 
C D 
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Figure 21 illustrates a series of plots of the change in the SPR angle versus the change 
in the SPR the peak minimum intensity from at least three repetitions and several 
concentrations when the MDCKII cell monolayer was exposed to propranolol or D-
mannitol. The plots illustrate that when the cell monolayer was exposed to increasing 
concentrations of D-mannitol, the SPR peak minimum intensity did not change or 
decreased only slightly (which is seen as a horizontal appearance in the plots). In the 
case of propranolol, the exposure induced a significantly higher decrease in the SPR 
peak minimum intensity and in the SPR angle at every concentration compared to D-
mannitol. This is visualized as a more vertical appearance in the plots. Moreover, the 
SPR peak intensity was shifted to a higher value after the exposure of propranolol when 
the MDCKII cells were flushed with pure buffer. This effect was not observed in the 
case of D-mannitol. These results clearly indicate that propranolol and D-mannitol 
interact differently with the MDCKII cell monolayer immobilized on the non-treated 
gold sensor chip. Generally, it is known that propranolol diffuses effectively by the 
transcellular pathway into cells whereas D-mannitol uses the paracellular pathway 
(Salama et al. 2003; Artursson 1990). This difference in the interaction between the test 
compound and the cell monolayer is observed not only in the SPR angle, but also in the 
SPR peak minimum intensity. The results propose that instead of analyzing only the 
change in the SPR angle during drug-cell interaction measurements it would be more 
reasonable to analyze both the SPR angle and SPR peak minimum intensity, and 
consequently plot them against each other in order to better understand and differentiate 
between the interactions between different drugs and cells. 
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Figure 21. Change in the SPR peak minimum intensity as a function of the change in the 
SPR angle, when MDCKII cells were exposed to propranolol (left) and D-mannitol 
(right). Individual SPR measurements as concentration series: A) 0,0025; B) 0,25; C) 
2,5; D) 25 and E) 250 !M which was followed by the dissociation in pure buffer. 
Different colors indicate independent experiments.  
 
 
The immobilized MDCKII cells were finally also exposed to several concentrations of 
D-glucose and HSPC:Chol liposomes. As illustrated in Figure 22, the exposure 
decreased the SPR angle in both cases, expect for the highest concentration of D-
glucose, where the angle increased, but only slightly when compared to propranolol 
(Figure 18B). The negative change in the SPR angle indicates that both of these test 
compounds also interacted with the MDCKII cell monolayer. After exposing cells to D-
glucose followed by exposure to pure buffer, the SPR angle shifted to higher angles 
than the baseline. The SPR angle shift for glucose was in the same order of magnitude 
as in the case of propranolol. This increase in the SPR angle indicated that the transport 
of D-glucose into the cells was actually detected by SPR. On the contrary the exposure 
of the cells to liposomes produced a decrease in the baseline suggesting that liposomes 
were not taken up by the cells within the time frame of the experiments.  
 
 
E 
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Figure 22. A) Measured changes in the SPR angle as a function of time when the 
immobilized MDCKII cells were exposed to D-glucose (mM) for 10 min. Down arrows 
represent the time of sample injections, and up arrows the time of the injection of a pure 
buffer. B) Maximum measured change in the SPR angle when MDCKII cells were 
exposed to 0,05; 0,5 and 5 mM D-glucose (n=4). The mean and standard errors of 
individual measurements are represented. C) Measured changes in the SPR angle as a 
function of time when the immobilized MDCKII cells were exposed to HSPC:Chol 
liposomes (mM) for 10 min. D) Maximum measured change in the SPR angle when 
MDCKII cells were exposed to 0,01; 0,1 and 1 mM HSPC:Chol liposomes (n=4).  
 
 
Figure 23 compares the SPR signals obtained during exposure of the MDCKII cells to 
the four different test compounds used in this study. One concentration level of each test 
compound was plotted in the same graph. As a result, it was found that propranolol and 
D-glucose induced a similar response, whereas D-mannitol and HSPC:Chol liposomes 
had similarities in their response. Indeed, propranolol and D-glucose induced changes 
both in the SPR peak minimum intensity and in the SPR angle, while D-mannitol and 
HSPC:Chol liposomes only induced a change in the SPR angle. These results verify that 
the differences in the interaction between the test compound and the immobilized 
A B 
C D 
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MDCKII cells can be observed by simultaneously monitoring the changes in both the 
SPR angle and the SPR peak minimum intensity.  
 
 
 
Figure 23. The change in the SPR peak minimum intensity as a function of the change 
in the SPR angle, when MDCKII cells were exposed to four different test compounds 
followed by the dissociation in pure buffer.  
 
 
 
5 DISCUSSION 
 
5.1 Growing of the cells on PDMS substrates 
 
ARPE-19 cells were grown on the PDMS substrates to study if it would be possible to 
culture this cell line on the PDMS molded flow channel of the SPR instrument. PDMS 
is biocompatible, but it is also a hydrophobic material (Wang et al. 2009; Lee et al. 
2004). It is generally known that hydrophobic substrates do not promote cell adhesion 
to the surface (Faucheux et al. 2004). Therefore ARPE-19 cells were not attaching to 
the PDMS substrates with a common 10:1 elastomer to curing agent mixing ratio. 
Krishna et al. (2007) have shown that unmodified PDMS does not support the 
attachment of ARPE-19 cells as good as polystyrene and Klenkler et al. (2005) reported 
that the epithelial cells did not grow as a confluent monolayer on this material. Similar 
results have also been obtained with Caco2-cells (Wang et. al 2009). 
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In order to improve the cell adhesion properties, PDMS substrates were treated with 
fibronectin, laminin, type I collagen and PLL. The attachment of ARPE-19 cells 
appeared to be highly dependent on the modification treatment. The micrographs and 
the viability test revealed that the most confluent and viable ARPE-19 cells were 
growing on the fibronectin-treated PDMS. Moreover, Liam et al. (2004) have 
successfully used fibronectin to increase the attachment of ARPE-19 cells on PDMS 
surfaces. Fibronectin, laminin and type I collagen are all fibrous proteins in the 
extracellular matrix, which are controlling the cell behavior in a native environment 
having both structural and adhesive functions (Folch and Toner 2000). However, 
Gugutkov et al. (2009) have suggested that fibronectin significantly enhances the 
attachment and proliferation of the cells on PDMS substrates, because its adsorption is 
higher on a hydrophobic surface than on a wettable surface. Moreover, fibronectin is 
relatively non-specific in promoting cell adhesion when laminin e.g. has more 
specificity towards a certain cell type (Carlsson et al. 1981). As the work progressed it 
became clear that visualizing ARPE-19 cells on the PDMS molded flow channel of the 
SPR instrument was too difficult (Figure 8). However, it was found that ARPE-19 cells 
could adhere directly on the surface of non-treated gold sensor chips. Therefore, the 
more straightforward process of seeding the cells directly on the non-treated gold sensor 
chips was selected for the SPR measurements. However, the preliminary results 
concerning the adhesion properties of the ARPE-19 cells on the PDMS molded flow 
channel of the SPR instrument may be valuable for future studies developing e.g. for 
developing a flow channel cell culture protocol for SPR analysis.   
 
5.2 Growing and viability of the cells on gold sensor chip 
 
Prior to SPR measurements, the cell culture conditions were optimized in order to grow 
the cells as a confluent monolayer on the gold sensor chips. The confluence of the 
immobilized cells was vital because Ziblat et al. (2006) have shown that the surface 
coverage of cells on the gold sensor chip has a dramatic effect on the shape of the full 
SPR angle curve. Therefore, in order to obtain repeatable SPR measurements and avoid 
unspecific interactions of the test compounds not originating from cell interactions, it is 
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important to develop a cell immobilization protocol that enables a repeatable culture of 
confluent monolayers on the SPR sensor chip. It was found that both ARPE-19 cells and 
MDCKII cells attached and proliferated as a confluent monolayer on the non-treated 
gold sensor chips when compared to fibronectin-treated gold sensor chips and the 
polystyrene (used as a reference cell culture material). Therefore, it was concluded that 
no adhesion promoter was required (Figure 9 and 11). Cells have been cultured on non-
treated gold sensor chips in also in previous SPR cell studies. Used cell lines included 
human melanoma (Yashunsky et al. 2009), human basophilic KU812 (Fujimura et al. 
2008), RBL-2H3 rat mast and PAM212 mouse keratinocyte cells (Yanase et al. 2007), 
to name a few. Moreover, Robelek and Weger (2010) have immobilized MDCKII cells 
directly on the gold sensor chip as a confluent monolayer to study the volume changes 
of cells. 
 
After reaching confluence, MDCKII cells started to form clusters on the smooth non-
treated gold sensor chip surface. Based on microscope visualization it seemed that 
liquid had gathered under the cells at the clustering points. Cells are generally attached 
to the surfaces in focal, close, and extracellular matrix contacts, each with its own 
characteristic separation distance from the surface (Chen and Singer 1982). As a result, 
cell plasma membranes are normally 10-100 nm away from the substrate surface 
depending on cell types and culturing conditions, but due to the cluster formation the 
plasma membranes could have been even further away in those zones in the case of 
MDCKII cells in this study. The detectable evanescent field of an SPR instrument is 
approximately 300 nm from the gold sensor chip surface and the height of cells is in the 
micrometer range meaning that some of the cells may have been out of the evanescent 
field due to the cluster formation. Therefore, those clusters may influence on the SPR 
results. However, this effect was minimized as much as possible by optimizing the 
seeding density. Trypan blue and MTT test showed that the non-treated gold sensor chip 
surface is not cytotoxic for ARPE-19 cells or MDCKII cells. 
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5.3 Resistance of cells to buffer flow 
 
The results from the flow experiments with the immobilizer demonstrated that MCDKII 
cells were able to resist shear stress induced by buffer flow much better than ARPE-19 
cells. This can probably be explained by the physiological location of the cells. ARPE-
19 cell line has been derived from the normal eyes of a 19-year-old male where the cells 
constitute a monolayer between the choroid and the neurosensory retina, while the 
MDCKII cell line has been derived from the distal tubule or the collecting duct of the 
nephron of a canine. The parameters that influence the shear stress are flow, radius and 
medium viscosity (Reneman et al. 2006). The blood flow in a 70 kg young healthy adult 
in kidneys is approximately 1240 ml/min while the blood flow in a human retina has 
been measured to be 0,261 ± 0,087 ml/min (Maleki et al. 2010; Davies and Morris 
1993). The shear stress is significantly higher in blood vessels in kidneys compared to 
the eye so it may be the reason why MDCKII tolerated the shear stress induced by 
buffer flow better than ARPE-19 cells. Moreover, these cell lines may also have 
differences in how strongly they interact with the gold surface, which can influence the 
ability of the cells to resist the buffer flow. The results indeed suggest that MDCKII 
cells adhere more strongly to the surface of the non-treated gold sensor chip than 
ARPE-19 cells. The flow experiments also indicated that when the cells were cultured a 
longer period than one day, the cells adhered stronger to the surface of the non-treated 
gold sensor chip and could better resist the shear stress induced by buffer flow. 
 
5.4 Surface plasmon resonance in living cell sensing 
 
The dominant SPR application for the past 20 years has been to measure different 
protein-protein and other biomolecular interactions in real-time without labeling (Rich 
and Myszka 2010; De Crescenzo et al. 2008). Traditionally, this has been done by 
measuring only changes in the SPR angle as a function of time. In this work not only 
the change in the SPR angle but also the change in the SPR peak minimum intensity 
was measured in order to further clarify if SPR is able to distinguish between 
differences in the interactions the test compounds and the immobilized MDCKII cells. 
The aim of this work was to study the suitability ability of the SPR technique to monitor 
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drug-cell interactions when cells were directly immobilized on the gold sensor chip. It 
was observed that the immobilized MDCKII cells induced rapid changes in the SPR 
angle when the cells were exposed to increasing concentrations of propranolol, D-
mannitol, D-glucose or HSPC:Chol liposomes. The change in the SPR angle showed 
that the immobilized cells were reacting to external stimuli. It should be noted that the 
detectable evanescent field on the gold sensor chip is approximately 300 nm, while the 
thickness of the MDCKII cell monolayer is approximately 6 µm meaning that the 
distance between the stimulated cell surface and the gold sensor chip surface is far 
longer than the detectable range (Kersting et al. 1993). The observed change in the SPR 
angle is therefore mainly due to the cellular response and the surface adsorption does 
not have a significant influence on the measured change in the SPR angle. For this 
reason, the transport process in the cell surface itself cannot be detected by the SPR 
instrument. The transport process still triggers intracellular mass redistribution, e.g. 
calcium mobilization or cytoskeleton remodeling, and these changes may generate a 
change in the SPR signal (Kholodenko 2003).  
 
The exposure of MDCKII cells to several concentrations of propranolol or D-mannitol 
caused a significant change in the SPR angle (Figure 18A and 20A). However, no 
significant change in the SPR angle was measured when propranolol or D-mannitol was 
allowed to interact with a no-treated gold sensor chip without the cells (Figure 18C and 
20C). As a result, this confirms that the measured change in the SPR angle during the 
interaction of the test compounds with the immobilized MDCKII cells actually shows 
real drug-cell interactions and not drug-gold interactions. This is true, because when a 
cell monolayer is present on the surface of the gold sensor chip then most of the sensor 
surface is not accessible to the test compound and this limits the contribution of a bulky 
effect by the test compound to a relatively small proportion of the total sensor area. 
Previously, Robelek and Wegener (2010) demonstrated in their study that the measured 
SPR signal reflects the cellular reactions of the immobilized MDCKII cells, and not a 
simple change in the bulk refractive index when the cells are stimulated with a test 
compound. They rinsed the gold sensor chip without the cells, and cell-covered gold 
sensor chip with 10% polyvinylpyrolidone in the running buffer to raise the bulk 
refractive index substantially without influencing buffer osmolarity. As a result, they 
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observed a radical signal shift with the gold sensor chip without the cells whereas the 
cell-covered gold sensor chip induced only a minor, very prolonged SPR signal change. 
 
The measured change in the SPR angle was negative for each concentration of 
propranolol and D-mannitol except for 250 µM propranolol for which it was positive 
(Figure 18 and 20). It is generally known that propranolol diffuses effectively by the 
transcellular pathway into cells, whereas D-mannitol uses the paracellular pathway 
(Salama et al. 2003; Polli et al. 2001). It was surprising that the exposure to D-mannitol 
induced a negative change in the SPR angle. It was expected that no change in the SPR 
angle should be observed because D-mannitol is not readily diffused into the cells. On 
the other hand, it was expected that propranolol induces a positive change in the SPR 
angle because propranolol should readily diffuse into the cells. A widely accepted 
simplification for the measured SPR signal is that the SPR angle is linearly proportional 
to the mass change in the evanescent field. It has been suggested in the literature that 
when cells are immobilized on the gold sensor chip of an SPR instrument, a shift in the 
SPR angle also correlates with the mass redistribution within the cells and not only the 
mass accumulation of the test compound within the cells (Yanase et al. 2007; Fang et al. 
2006). This mass redistribution is a sum of all redistribution events within the 
evanescent field occurring at different distances away from the surface of the gold 
sensor chip. The mass redistribution could indeed induce either negative or positive 
changes in the measured SPR angle depending on if the intracellular mass migration 
within the cells is in the direction away from or towards the SPR evanescent field 
during the exposure of the test compound. Based on these results, the negative changes 
in the SPR angle with propranolol and D-mannitol would suggest that the exposure 
induced a mass redistribution away from the evanescent field in both cases.  
 
Only the highest concentration of propranolol (250 !M) induced first a negative shift 
accompanied with a major positive shift in the SPR angle (Figure 18) indicating that 
first propranolol initially induced a mass redistribution away from the evanescent field 
followed by a mass redistribution towards the evanescent field. This result suggests that 
when the immobilized MDCKII cells are exposed to a low concentration of propranolol 
it induces a cell contraction followed by mass redistribution away from the evanescent 
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field, which is observed as a negative change in the SPR angle. However, the highest 
concentration of propranolol will induce both a mass redistribution and/or 
morphological changes towards the evanescent field and an accumulation of 
propranolol within the cells. Consequently, a positive change in the SPR angle during 
the exposure is not observed at low concentrations of propranolol because the amount of 
absorbed propranolol is not sufficient to render the SPR angle positive. Similar behavior 
has been illustrated for HEK-293 cells stimulated with angiotensin II by verifying the 
results with phase-contrast microscopy imaging (Cuerrier et al. 2008). This is also 
further supported by the studies by Yashunsky et al. (2009). Cuerrier et al. (2008) 
showed that the contraction of cells induces a negative SPR shift in the fixed angle 
intensity, while Yashunsky et al. (2009) showed that the cell spreading induces an 
increase in the fixed angle intensity with mid infra-red SPR. Based on the discussion 
above, the negative change in the SPR angle when the immobilized MDCKII cells were 
exposed to propranolol, D-mannitol, D-glucose and HSPC:Chol liposomes may be an 
indication of a cell contraction induced by the test compound. 
 
All SPR studies in the literature involving the immobilization of cells on the gold sensor 
chip only monitors the change either in the SPR angle or the intensity change at a fixed 
angle near the minimum of the SPR peak, and none has observed that together with the 
change in the SPR peak minimum intensity (Chabot et al. 2009; Fujimura et al. 2008; 
Yanase et al. 2007). When comparing the measured change in the SPR peak minimum 
intensity between propranolol and D-mannitol, only the exposure to propranolol 
changed the SPR peak minimum intensity (Figure 21). Propranolol induced a negative 
change in the SPR peak minimum intensity at low concentrations, but for the highest 
concentration it was positive. In other words, the propranolol induced a change in both 
the SPR angle and the SPR peak minimum intensity, while D-mannitol induced only a 
change in the SPR angle. Based on these results, it is clear that the stimulation with a 
drug, which diffuses into cells transcellularly, induces a change in both the SPR angle 
and the SPR peak minimum intensity, while a drug which is absorbed paracellularly 
induces only a change in the SPR angle. These results indicate that when the 
immobilized MDCKII cells are exposed to propranolol it triggers intracellular mass 
redistribution within the cells, while D-mannitol does not. Because the SPR peak 
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minimum intensity changed only in the case of propranolol, these findings strongly 
suggest that the change in the SPR angle indicates cell contradiction (a negative change) 
or cell spreading (a positive change), while the change in the SPR peak minimum 
intensity reveals the accumulation/depletion of the test compound and/or the 
intracellular mass redistribution within the cells.  
 
The discussion above is supported by the observation that D-glucose which is 
transported via carriers into the cells also induced a change in the SPR peak minimum 
intensity, while HSPC:Chol liposomes produced only a minor change (Figure 23). The 
liposomes are actively transported into cells by endocytosis, but the interaction time 
(maximum 10 min) between the immobilized MDCKII cells and HSPC:Chol liposomes 
was probably too short for the endocytosis to take place (Lee et al. 1993). The process 
of liposomal uptake is a two-step process consisting of liposome binding to cell surface 
sites followed by endocytosis (Miller et al. 1998). Due to a short analysis time, only the 
cell response induced by interaction between liposomes and the cell surface could be 
detected by the SPR instrument. 
 
Moreover, it was shown that after the exposure of propranolol the baseline was shifted 
to a higher value when both the SPR angle and the SPR peak minimum intensity was 
observed. In the case of D-mannitol the baseline of the SPR angle and the SPR peak 
minimum intensity basically returned to the same level as before exposure. These 
results also supports the finding that during the exposure of MDCKII cells to 
propranolol, it was readily diffused transcellularly into the immobilized cells, and after 
the exposure a part of the accumulated propranolol remained in the cells increasing the 
baseline level. Clearly, the accumulation of D-mannitol within the cells was not 
observed because D-mannitol is transported by a paracellular pathway (Salama et al. 
2003). This is also supported by the fact that the change in the SPR angle was basically 
constant for all concentration and much smaller in the case of D-mannitol compared to 
propranolol. In addition, as illustrated in Figure 22, the increase in the baseline of the 
measured SPR angle after the exposure was also observed when MDCKII cells were 
exposed to D-glucose, which is transported into cells via transporters (Wang et al. 
1997). However, any quantitative analysis of these results was not possible at the time 
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of the studies due to the lack of proper analysis tools. However, the results from this 
study combined with further drug-cell interaction studies with SPR could in the future 
allow for the development of proper tools for quantitative analysis of the SPR responses 
in living cell sensing.    
 
It should be mentioned that in this work, there was a clear variation in the results of the 
SPR measurements. The SPR angular scan changed when MDCKII cells with a higher 
passage number were used in the measurements. The SPR measurements in this work 
were done with passage number 15-29 for MDCKII cells. In the first measurements, the 
results were more repeatable than in those that were performed later. Based on the 
results, it is practical to use only lower passage numbers of MDCKII cells in the cell-
based assays with optical biosensors. The SPR peak minimum intensity and the SPR 
angle are sensitive to the cell density and viability meaning that the biological status of 
cells, e.g. cell viability, cell density and degree of adhesion, can significantly influence 
the results and cause assay variability (Horvath et al. 2001). In the measurements in this 
study, the confluence of the cell monolayer on the gold sensor chip was ensured by the 
flow experiments and microscopic visualizations before each measurement. However, 
when MDCKII cells were grown as a confluent monolayer on the non-treated gold 
sensor chips, the cells were often forming clusters despite the attempt to optimize the 
cell culture conditions, which could have an effect on the SPR signals. Moreover, the 
optical signal can be dependent on the cell states (Fang et al. 2005). If cells are in a 
proliferating state, the response of the cells to the stimulation with a test compound may 
be different and therefore induce assay variability. It is clear that further studies with 
several drugs are required that reliable conclusions can be drawn. It may be 
advantageous in the future to perform the SPR measurements with one concentration 
level at a time and allow the test compound and the immobilized cells to interact for a 
longer period of time. This may facilitate a better quantitative and not only qualitative 
the interpretation of the results. 
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6 CONCLUSIONS 
 
This study shows that SPR has the capacity to determine cellular activity in real-time 
when cells immobilized on the SPR sensor chip are stimulated with various agents. 
MDCKII and ARPE-19 cells can be cultured on the gold sensor chip, but only MDCKII 
cells can resist harsh conditions, such as flow and ambient temperature, during the SPR 
measurements. This indicates that the cell type used need to be firmly attached to the 
sensing surface. The results show that when both the change in the SPR angle and the 
SPR peak minimum intensity are simultaneously monitored it improves the mechanistic 
understanding of the SPR responses in living cell sensing compared to cases when only 
the changed in the SPR angle is monitored. The approach demonstrated in this work 
also enables to differentiate between the type and modes of drug actions when 
monitoring drug-cell interactions by SPR. This was clearly demonstrated by using two 
drugs that utilizes different absorption pathways as test compounds, i.e. propranolol 
(transcellular) and D-mannitol (paracellular). Hence, SPR may be a potential in vitro 
method in order to provide real-time complementary information on the permeability of 
drugs and possibly also about cell uptake mechanisms of nanoparticles for traditional in 
vitro cell assays for a better mechanistic understanding of drug-cell interactions on a 
cellular level.  
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